Staphylococcus aureus MRSA is a mesophilic human pathogen that has multiple antibiotic resistances and was isolated from blood.
antibiotic resistance mesophilic human pathogen genome sequence 16S sequence| @ref 20215 |
Last LPSN update
2025-12-16 09:50:21 |
| Domain Bacillati |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 4460 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 4460 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 4460 | positive | growth | 37 | mesophilic |
| Test 1 | Test 2 | Test 3 | Test 4 | Test 5 | Test 6 | Test 7 | Test 8 | Test 9 | Test 10 | Test 11 | Test 12 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| @ref | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 | 4460 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar |
| Incubation temperature | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | ||
| Incubation time | 1 | 1 | ||||||||||
| Oxygen condition | aerob | aerob | aerob | aerob | aerob | |||||||
| Manual_annotation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Penicillin G | 20 | 20 | 10 | 10 | 6 | 0 | 0 | 0 | 6-8 | 8-10 | 8-10 | 10 |
| Oxacillin | 28 | 28 | 8 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ampicillin | 20 | 20 | 10-12 | 10 | 10 | 0 | 8 | 0 | 8-10 | 10 | 10 | 12 |
| Ticarcillin | 24 | 24-26 | 14 | 12-14 | 12 | 6 | 6 | 8 | 10 | 10-12 | 10-12 | 16-18 |
| Mezlocillin | 20 | 20 | 10 | 10 | 8-10 | 0 | 0 | 0 | 10 | 10 | 10 | 12 |
| Cefalotin | 32 | 34 | 12-14 | 14 | 8-10 | 6 | 8 | 6 | 10 | 10-12 | 10-12 | 20 |
| Cefazolin | 28-30 | 32 | 10-12 | 10-12 | 0 | 0 | 0 | 8 | 0 | 10 | 10 | 0 |
| Cefotaxime | 30-32 | 28-30 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 10 | 10 | 0 |
| Aztreonam | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Imipenem | 48-50 | 48 | 16 | 22 | 12 | 6 | 0 | 6 | 10 | 14-16 | 14-16 | 28-30 |
| Tetracycline | 12 | 12-14 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Chloramphenicol | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 10 | 8 | 8 | 10 |
| Gentamycin | 24 | 26 | 24 | 26 | 24 | 14 | 14 | 12 | 28 | 24-26 | 24-26 | 24 |
| Amikacin | 22 | 22-24 | 22 | 24 | 22 | 12 | 12 | 12 | 24 | 20-22 | 20-22 | 22 |
| Vancomycin | 20 | 20 | 20 | 18-20 | 20 | 12 | 12 | 10 | 22 | 20 | 20 | 20 |
| Erythromycin | 6-8 | 10 | 10 | 10 | 10 | 6 | 6 | 6 | 12 | 10-12 | 10-12 | 12 |
| Lincomycin | 30 | 30 | 32 | 34 | 30-32 | 16 | 14 | 16 | 32 | 32 | 32 | 34 |
| Ofloxacin | 30 | 30-32 | 30-32 | 30 | 30 | 16 | 14 | 18 | 32 | 30 | 30 | 32 |
| Norfloxacin | 26-28 | 30 | 30 | 30 | 30-32 | 16 | 16 | 20 | 30-32 | 28-30 | 28-30 | 32 |
| Colistin | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pipemidic acid | 12 | 16 | 12 | 14 | 12-14 | 8 | 8 | 10 | 12 | 10-12 | 10-12 | 14 |
| Nitrofurantoin | 26 | 30 | 28 | 28 | 28 | 16 | 16 | 14 | 30 | 28 | 28 | 30 |
| Bacitracin | 28 | 26 | 28 | 28 | 26-28 | 20 | 18 | 18 | 28 | 26 | 26 | 28 |
| Polymyxin b | 10 | 6 | 8 | 10 | 8 | 0 | 0 | 6 | 6-8 | 8 | 8 | 6 |
| Kanamycin | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Neomycin | 12 | 12-14 | 14 | 12 | 10 | 6 | 6 | 10 | 10-12 | 12 | 12 | 12 |
| Doxycycline | 20 | 20 | 10 | 10 | 10-12 | 8 | 8 | 8 | 14 | 10 | 10 | 12 |
| Ceftriaxone | 30 | 32-34 | 8 | 8-10 | 0 | n.d. | n.d. | n.d. | n.d. | 8 | 8 | 0 |
| Clindamycin | 38 | 38-40 | 38-40 | 40 | 36 | n.d. | n.d. | n.d. | n.d. | 40 | 40 | 40 |
| Fosfomycin | 30-32 | 30-32 | 28-30 | 30-32 | 32 | n.d. | n.d. | n.d. | n.d. | 30-32 | 30-32 | 32 |
| Moxifloxacin | 34 | 36 | 34-36 | 36 | 34 | n.d. | n.d. | n.d. | n.d. | 34-36 | 34-36 | 36 |
| Linezolid | 36 | 34-36 | 30 | 34 | 28-30 | n.d. | n.d. | n.d. | n.d. | 32-34 | 32-34 | 38 |
| Nystatin | 0 | 0 | 0 | 0 | 0 | n.d. | n.d. | n.d. | n.d. | 0 | 0 | 0 |
| Quinupristin/dalfopristin | 28-30 | 28 | 28 | 28 | 28 | n.d. | n.d. | n.d. | n.d. | 30 | 30 | 30 |
| Teicoplanin | 18 | 18 | 16-18 | 18 | 18 | n.d. | n.d. | n.d. | n.d. | 18 | 18 | 18 |
| Piperacillin/tazobactam | 26 | 26 | 12 | 12-14 | 12 | n.d. | n.d. | n.d. | n.d. | 12-14 | 12-14 | 14-16 |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 91.5 |
| 4460 | Observationnot MRSA |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 16988 ChEBI | D-ribose | - | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | + | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 4460 | catalase | + | 1.11.1.6 | |
| 4460 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4460 | + | + | - | - | + | + | + | + | + | + | + | + | - | - | + | + | - | + | + | - | + | + | + | + | - | - | |
| 4460 | - | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | +/- | + | + | + | - | - | |
| 4460 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | + | + | + | + | - | - | |
| 4460 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - | |
| 4460 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | +/- | +/- | + | + | + | - | - | |
| 4460 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - | |
| 4460 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | + | + | + | + | - | - | |
| 4460 | - | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | +/- | + | + | + | - | - | |
| 4460 | - | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM101863v2 assembly for Staphylococcus aureus FDAARGOS_3 | contig | GCA_001018635   | 1280.4837  | 2663762642  | 1280 | 75.55 | |
| 66792 | 12673_5#80 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082945 | 1280 | 75.11 | | ||
| 66792 | 12673_3#66 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082345 | 1280 | 75.06 | | ||
| 66792 | 12625_5#64 assembly for Staphylococcus aureus 2588STDY5748061 | scaffold | GCA_001289405 | 2690315761 | 1280 | 75.02 | | |
| 66792 | 12673_3#18 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082285 | 1280 | 74.95 | | ||
| 66792 | 12673_2#11 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081935 | 1280 | 74.89 | | ||
| 66792 | 12673_5#13 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082465 | 1280 | 74.81 | | ||
| 66792 | 12971_2#31 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083125 | 1280 | 74.73 | | ||
| 66792 | 12673_5#9 assembly for Staphylococcus aureus 2588STDY5748867 | scaffold | GCA_001288325 | 2690315800 | 1280 | 74.53 | | |
| 66792 | 12971_2#23 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083115 | 1280 | 74.51 | | ||
| 66792 | 12673_1#83 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081905 | 1280 | 74.46 | | ||
| 66792 | 12673_5#69 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082855 | 1280 | 74.37 | | ||
| 66792 | 12971_3#59 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083405 | 1280 | 74.32 | | ||
| 66792 | 12673_5#59 assembly for Staphylococcus aureus 2588STDY5748917 | scaffold | GCA_001287805 | 2681813298 | 1280 | 74.3 | | |
| 66792 | 12673_2#3 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082025 | 1280 | 74.16 | | ||
| 66792 | 12673_1#28 assembly for Staphylococcus aureus 2588STDY5748506 | scaffold | GCA_001287665 | 2681813296 | 1280 | 74.16 | | |
| 66792 | 12673_5#31 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082575 | 1280 | 74.08 | | ||
| 66792 | 12673_5#20 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082505 | 1280 | 73.97 | | ||
| 66792 | 12673_3#19 assembly for Staphylococcus aureus 2588STDY5748687 | scaffold | GCA_001289505 | 2690315791 | 1280 | 73.94 | | |
| 66792 | 12673_5#51 assembly for Staphylococcus aureus 2588STDY5748909 | scaffold | GCA_001291025 | 2703719415 | 1280 | 73.88 | | |
| 66792 | 12673_5#8 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082935 | 1280 | 73.86 | | ||
| 66792 | 12673_5#85 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082985 | 1280 | 73.85 | | ||
| 66792 | 12673_8#21 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083065 | 1280 | 73.84 | | ||
| 66792 | 12625_6#15 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900080965 | 1280 | 73.84 | | ||
| 66792 | 12673_5#56 assembly for Staphylococcus aureus 2588STDY5748914 | scaffold | GCA_001288545 | 2690315788 | 1280 | 73.83 | | |
| 66792 | 12625_6#5 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081035 | 1280 | 73.78 | | ||
| 66792 | 12673_5#21 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082515 | 1280 | 73.76 | | ||
| 66792 | 12673_3#36 assembly for Staphylococcus aureus 2588STDY5748704 | scaffold | GCA_001287625 | 2671181077 | 1280 | 73.74 | | |
| 66792 | 12673_1#82 assembly for Staphylococcus aureus 2588STDY5748560 | scaffold | GCA_001287865 | 2690315774 | 1280 | 73.74 | | |
| 66792 | 12625_6#54 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081055 | 1280 | 73.68 | | ||
| 66792 | 12673_5#64 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082805 | 1280 | 73.66 | | ||
| 66792 | 12673_5#76 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082905 | 1280 | 73.65 | | ||
| 66792 | 12673_1#68 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081885 | 1280 | 73.6 | | ||
| 66792 | 12673_5#32 assembly for Staphylococcus aureus 2588STDY5748890 | scaffold | GCA_001289785 | 2703719414 | 1280 | 73.59 | | |
| 66792 | 12673_5#88 assembly for Staphylococcus aureus 2588STDY5748946 | scaffold | GCA_001288745 | 2703718935 | 1280 | 73.55 | | |
| 66792 | 12673_5#37 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082605 | 1280 | 73.53 | | ||
| 66792 | 12625_6#86 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081185 | 1280 | 73.5 | | ||
| 66792 | 12625_6#68 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081085 | 1280 | 73.49 | | ||
| 66792 | 12673_5#11 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082435 | 1280 | 73.44 | | ||
| 66792 | 12673_2#20 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081975 | 1280 | 73.37 | | ||
| 66792 | 12673_5#45 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082695 | 1280 | 73.34 | | ||
| 66792 | 12673_5#50 assembly for Staphylococcus aureus 2588STDY5748908 | scaffold | GCA_001289065 | 2681813293 | 1280 | 73.33 | | |
| 66792 | 12673_5#90 assembly for Staphylococcus aureus 2588STDY5748948 | scaffold | GCA_001288565 | 2703718936 | 1280 | 73.31 | | |
| 66792 | 12625_6#84 assembly for Staphylococcus aureus 2588STDY5748178 | scaffold | GCA_001288785 | 2671180496 | 1280 | 73.31 | | |
| 66792 | 12673_5#38 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082625 | 1280 | 73.25 | | ||
| 66792 | 12673_1#50 assembly for Staphylococcus aureus 2588STDY5748528 | scaffold | GCA_001289365 | 2671181168 | 1280 | 73.25 | | |
| 66792 | 12625_6#70 assembly for Staphylococcus aureus 2588STDY5748164 | scaffold | GCA_001290225 | 2690315771 | 1280 | 73.25 | | |
| 66792 | 12673_5#78 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082925 | 1280 | 73.24 | | ||
| 66792 | 12673_2#76 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082185 | 1280 | 73.21 | | ||
| 66792 | 12625_6#31 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900080985 | 1280 | 73.21 | | ||
| 66792 | 12673_5#79 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082955 | 1280 | 73.2 | | ||
| 66792 | 12673_2#35 assembly for Staphylococcus aureus 2588STDY5748608 | scaffold | GCA_001290625 | 2675903439 | 1280 | 73.16 | | |
| 66792 | 12673_5#15 assembly for Staphylococcus aureus 2588STDY5748873 | scaffold | GCA_001290465 | 2703718930 | 1280 | 73.15 | | |
| 66792 | 12673_3#83 assembly for Staphylococcus aureus 2588STDY5748751 | scaffold | GCA_001287965 | 2698536346 | 1280 | 73.14 | | |
| 66792 | 12673_5#82 assembly for Staphylococcus aureus 2588STDY5748940 | scaffold | GCA_001288265 | 2671180754 | 1280 | 73.14 | | |
| 66792 | 12673_3#59 assembly for Staphylococcus aureus 2588STDY5748727 | scaffold | GCA_001289805 | 2703718924 | 1280 | 73.14 | | |
| 66792 | 12625_6#78 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081145 | 1280 | 73.06 | | ||
| 66792 | 12641_3#20 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081525 | 1280 | 73.05 | | ||
| 66792 | 12673_1#19 assembly for Staphylococcus aureus 2588STDY5748497 | scaffold | GCA_001289585 | 2703718918 | 1280 | 73.02 | | |
| 66792 | 12673_3#20 assembly for Staphylococcus aureus 2588STDY5748688 | scaffold | GCA_001288825 | 2703718920 | 1280 | 72.99 | | |
| 66792 | 12673_5#3 assembly for Staphylococcus aureus 2588STDY5748861 | scaffold | GCA_001287565 | 2681813287 | 1280 | 72.97 | | |
| 66792 | 12673_3#28 assembly for Staphylococcus aureus 2588STDY5748696 | scaffold | GCA_001288185 | 2695420760 | 1280 | 72.95 | | |
| 66792 | 12673_3#35 assembly for Staphylococcus aureus 2588STDY5748703 | scaffold | GCA_001287885 | 2698536644 | 1280 | 72.94 | | |
| 66792 | 12673_5#72 assembly for Staphylococcus aureus 2588STDY5748930 | scaffold | GCA_001288685 | 2698536662 | 1280 | 72.94 | | |
| 66792 | 12673_5#44 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082685 | 1280 | 72.93 | | ||
| 66792 | 12673_5#46 assembly for Staphylococcus aureus 2588STDY5748904 | scaffold | GCA_001290285 | 2681813297 | 1280 | 72.92 | | |
| 66792 | 12673_5#65 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082815 | 1280 | 72.89 | | ||
| 66792 | 12673_8#20 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083055 | 1280 | 72.88 | | ||
| 66792 | 12971_3#89 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083475 | 1280 | 72.88 | | ||
| 66792 | 12673_5#47 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082705 | 1280 | 72.88 | | ||
| 66792 | 12673_1#34 assembly for Staphylococcus aureus 2588STDY5748512 | scaffold | GCA_001290125 | 2703718919 | 1280 | 72.87 | | |
| 66792 | 12673_5#43 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082675 | 1280 | 72.86 | | ||
| 66792 | 12641_3#35 assembly for Staphylococcus aureus 2588STDY5748417 | scaffold | GCA_001290205 | 2703719405 | 1280 | 72.85 | | |
| 66792 | 12625_6#7 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081105 | 1280 | 72.83 | | ||
| 66792 | 12673_2#82 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082215 | 1280 | 72.75 | | ||
| 66792 | 12673_3#43 assembly for Staphylococcus aureus 2588STDY5748711 | scaffold | GCA_001289525 | 2703719412 | 1280 | 72.75 | | |
| 66792 | 12673_5#33 assembly for Staphylococcus aureus 2588STDY5748891 | scaffold | GCA_001290425 | 2703718932 | 1280 | 72.75 | | |
| 66792 | 12625_6#8 assembly for Staphylococcus aureus 2588STDY5748102 | scaffold | GCA_001288225 | 2690315766 | 1280 | 72.74 | | |
| 66792 | 12673_3#6 assembly for Staphylococcus aureus 2588STDY5748674 | scaffold | GCA_001288645 | 2703719411 | 1280 | 72.74 | | |
| 66792 | 12625_5#22 assembly for Staphylococcus aureus 2588STDY5748019 | scaffold | GCA_001289565 | 2671180436 | 1280 | 72.74 | | |
| 66792 | 12673_3#22 assembly for Staphylococcus aureus 2588STDY5748690 | scaffold | GCA_001291325 | 2703718921 | 1280 | 72.74 | | |
| 66792 | 12673_5#29 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082565 | 1280 | 72.72 | | ||
| 66792 | 12673_2#91 assembly for Staphylococcus aureus 2588STDY5748664 | scaffold | GCA_001290305 | 2698536396 | 1280 | 72.69 | | |
| 66792 | 12971_2#43 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083135 | 1280 | 72.68 | | ||
| 66792 | 12673_3#77 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082355 | 1280 | 72.68 | | ||
| 66792 | 12673_5#71 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082875 | 1280 | 72.65 | | ||
| 66792 | 12625_2#19 assembly for Staphylococcus aureus 2588STDY5747536 | scaffold | GCA_001289485 | 2703718904 | 1280 | 72.59 | | |
| 66792 | 12673_5#19 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082495 | 1280 | 72.58 | | ||
| 66792 | 12625_5#56 assembly for Staphylococcus aureus 2588STDY5748053 | scaffold | GCA_001291205 | 2703718911 | 1280 | 72.57 | | |
| 66792 | 12641_3#2 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081515 | 1280 | 72.56 | | ||
| 66792 | 12673_5#14 assembly for Staphylococcus aureus 2588STDY5748872 | scaffold | GCA_001287945 | 2698536532 | 1280 | 72.54 | | |
| 66792 | 12673_3#12 assembly for Staphylococcus aureus 2588STDY5748680 | scaffold | GCA_001288245 | 2671180471 | 1280 | 72.54 | | |
| 66792 | 12625_6#52 assembly for Staphylococcus aureus 2588STDY5748146 | scaffold | GCA_001289245 | 2671180605 | 1280 | 72.54 | | |
| 66792 | 12673_3#34 assembly for Staphylococcus aureus 2588STDY5748702 | scaffold | GCA_001290765 | 2703718922 | 1280 | 72.54 | | |
| 66792 | 12673_3#49 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082325 | 1280 | 72.52 | | ||
| 66792 | 12673_1#74 assembly for Staphylococcus aureus 2588STDY5748552 | scaffold | GCA_001288005 | 2681813286 | 1280 | 72.52 | | |
| 66792 | 12673_3#75 assembly for Staphylococcus aureus 2588STDY5748743 | scaffold | GCA_001289705 | 2703718927 | 1280 | 72.52 | | |
| 66792 | 12673_5#54 assembly for Staphylococcus aureus 2588STDY5748912 | scaffold | GCA_001287585 | 2703719361 | 1280 | 72.49 | | |
| 66792 | 12673_5#57 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082755 | 1280 | 72.48 | | ||
| 66792 | 12673_1#2 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081755 | 1280 | 72.44 | | ||
| 66792 | 12673_1#58 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081855 | 1280 | 72.42 | | ||
| 66792 | 12673_5#27 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082545 | 1280 | 72.35 | | ||
| 66792 | 12673_3#58 assembly for Staphylococcus aureus 2588STDY5748726 | scaffold | GCA_001289385 | 2703718925 | 1280 | 72.25 | | |
| 66792 | 12641_3#18 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081495 | 1280 | 72.24 | | ||
| 66792 | 12673_3#50 assembly for Staphylococcus aureus 2588STDY5748718 | scaffold | GCA_001288045 | 2698536468 | 1280 | 72.24 | | |
| 66792 | 12673_5#26 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082535 | 1280 | 72.23 | | ||
| 66792 | 12673_5#87 assembly for Staphylococcus aureus 2588STDY5748945 | scaffold | GCA_001288845 | 2681813289 | 1280 | 72.21 | | |
| 66792 | 12673_1#10 assembly for Staphylococcus aureus 2588STDY5748488 | scaffold | GCA_001290805 | 2703719407 | 1280 | 72.15 | | |
| 66792 | 12971_3#74 assembly for Staphylococcus aureus 2588STDY5764007 | scaffold | GCA_001288985 | 2681813295 | 1280 | 72.13 | | |
| 66792 | 12673_5#55 assembly for Staphylococcus aureus 2588STDY5748913 | scaffold | GCA_001290845 | 2703718934 | 1280 | 72.11 | | |
| 66792 | 12673_5#91 assembly for Staphylococcus aureus 2588STDY5748949 | scaffold | GCA_001287985 | 2698536523 | 1280 | 72.06 | | |
| 66792 | 12625_6#53 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081045 | 1280 | 72.01 | | ||
| 66792 | 12971_2#86 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083205 | 1280 | 71.97 | | ||
| 66792 | 12673_3#27 assembly for Staphylococcus aureus 2588STDY5748695 | scaffold | GCA_001291225 | 2671180491 | 1280 | 71.97 | | |
| 66792 | 12673_5#16 assembly for Staphylococcus aureus 2588STDY5748874 | scaffold | GCA_001288925 | 2698536625 | 1280 | 71.9 | | |
| 66792 | 12673_2#88 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082225 | 1280 | 71.83 | | ||
| 66792 | 12625_6#29 assembly for Staphylococcus aureus 2588STDY5748123 | scaffold | GCA_001287545 | 2693429531 | 1280 | 71.79 | | |
| 66792 | 12673_5#12 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082455 | 1280 | 71.76 | | ||
| 66792 | 12673_3#2 assembly for Staphylococcus aureus 2588STDY5748670 | scaffold | GCA_001290925 | 2703719410 | 1280 | 71.75 | | |
| 66792 | 12971_3#51 assembly for Staphylococcus aureus 2588STDY5763984 | scaffold | GCA_001290785 | 2681813290 | 1280 | 71.73 | | |
| 66792 | 12971_3#49 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083375 | 1280 | 71.6 | | ||
| 66792 | 12971_3#90 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083495 | 1280 | 71.53 | | ||
| 66792 | 12673_2#94 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082245 | 1280 | 71.5 | | ||
| 66792 | 12971_2#15 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083095 | 1280 | 71.48 | | ||
| 66792 | 12625_6#22 assembly for Staphylococcus aureus 2588STDY5748116 | scaffold | GCA_001287845 | 2703719359 | 1280 | 71.42 | | |
| 66792 | 12971_3#18 assembly for Staphylococcus aureus 2588STDY5763951 | scaffold | GCA_001287825 | 2703718941 | 1280 | 71.36 | | |
| 66792 | 12673_2#24 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081995 | 1280 | 71.01 | | ||
| 66792 | 12673_2#39 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082045 | 1280 | 71 | | ||
| 66792 | 12625_5#24 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900080855 | 1280 | 71 | | ||
| 66792 | 12641_1#80 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081295 | 1280 | 70.93 | | ||
| 66792 | 12673_5#25 assembly for Staphylococcus aureus 2588STDY5748883 | scaffold | GCA_001287685 | 2695420768 | 1280 | 70.93 | | |
| 66792 | 12625_5#40 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900080875 | 1280 | 70.81 | | ||
| 66792 | 12971_3#81 assembly for Staphylococcus aureus 2588STDY5764014 | scaffold | GCA_001288105 | 2703719363 | 1280 | 70.78 | | |
| 66792 | 12673_2#55 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082115 | 1280 | 70.68 | | ||
| 66792 | 12641_2#51 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081395 | 1280 | 70.67 | | ||
| 66792 | 12641_3#43 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081605 | 1280 | 70.66 | | ||
| 66792 | 12673_1#26 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081775 | 1280 | 70.61 | | ||
| 66792 | 12673_5#62 assembly for Staphylococcus aureus 2588STDY5748920 | scaffold | GCA_001290365 | 2675903615 | 1280 | 70.58 | | |
| 66792 | 12625_6#85 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081165 | 1280 | 70.42 | | ||
| 66792 | 12625_6#93 assembly for Staphylococcus aureus 2588STDY5748187 | scaffold | GCA_001288405 | 2671181107 | 1280 | 70.41 | | |
| 66792 | 12673_5#18 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082485 | 1280 | 70.28 | | ||
| 66792 | 12641_2#27 assembly for Staphylococcus aureus 2588STDY5748313 | scaffold | GCA_001289965 | 2703719404 | 1280 | 70.15 | | |
| 66792 | 12673_5#74 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082895 | 1280 | 70.13 | | ||
| 66792 | 12673_1#36 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081805 | 1280 | 70.05 | | ||
| 66792 | 12673_5#94 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083035 | 1280 | 69.98 | | ||
| 66792 | 12625_6#38 assembly for Staphylococcus aureus 2588STDY5748132 | scaffold | GCA_001290725 | 2698536445 | 1280 | 69.88 | | |
| 66792 | 12673_5#34 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082595 | 1280 | 69.8 | | ||
| 66792 | 12641_1#72 assembly for Staphylococcus aureus 2588STDY5747973 | scaffold | GCA_001291005 | 2703719403 | 1280 | 69.75 | | |
| 66792 | 12971_3#91 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083505 | 1280 | 69.71 | | ||
| 66792 | 12641_2#58 assembly for Staphylococcus aureus 2588STDY5748344 | scaffold | GCA_001288765 | 2671180375 | 1280 | 69.54 | | |
| 66792 | 12673_3#42 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082305 | 1280 | 69.48 | | ||
| 66792 | 12641_2#50 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081385 | 1280 | 69.44 | | ||
| 66792 | 12641_1#63 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081245 | 1280 | 69.26 | | ||
| 66792 | 12625_6#23 assembly for Staphylococcus aureus 2588STDY5748117 | scaffold | GCA_001288445 | 2671181140 | 1280 | 69.26 | | |
| 66792 | 12625_6#69 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081095 | 1280 | 69.24 | | ||
| 66792 | 12625_6#6 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081065 | 1280 | 69.14 | | ||
| 66792 | 12673_5#42 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082635 | 1280 | 69.02 | | ||
| 66792 | 12673_3#57 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082335 | 1280 | 69 | | ||
| 66792 | 12625_6#55 assembly for Staphylococcus aureus 2588STDY5748149 | scaffold | GCA_001288885 | 2675903635 | 1280 | 68.83 | | |
| 66792 | 12673_5#83 assembly for Staphylococcus aureus 2588STDY5748941 | scaffold | GCA_001289925 | 2695420894 | 1280 | 68.49 | | |
| 66792 | 12673_5#86 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082995 | 1280 | 68.11 | | ||
| 66792 | 12673_5#73 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082885 | 1280 | 68.08 | | ||
| 66792 | 12641_1#64 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081255 | 1280 | 67.96 | | ||
| 66792 | 12625_6#46 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081025 | 1280 | 67.88 | | ||
| 66792 | 12641_3#36 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081575 | 1280 | 67.82 | | ||
| 66792 | 12673_5#63 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082825 | 1280 | 67.79 | | ||
| 66792 | 12641_2#26 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081335 | 1280 | 67.56 | | ||
| 66792 | 12971_3#50 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083385 | 1280 | 67.45 | | ||
| 66792 | 12625_6#13 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900080945 | 1280 | 67.42 | | ||
| 66792 | 12673_5#23 assembly for Staphylococcus aureus 2588STDY5748881 | scaffold | GCA_001290525 | 2703718931 | 1280 | 67.08 | | |
| 66792 | 12971_3#58 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083365 | 1280 | 66.93 | | ||
| 66792 | 12673_5#5 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082725 | 1280 | 66.66 | | ||
| 66792 | 12673_5#61 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082795 | 1280 | 66.61 | | ||
| 66792 | 12971_3#66 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900083425 | 1280 | 66.55 | | ||
| 66792 | 12625_6#79 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081155 | 1280 | 65.18 | | ||
| 66792 | 12625_6#77 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081135 | 1280 | 64.95 | | ||
| 66792 | 12673_5#36 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082615 | 1280 | 64.66 | | ||
| 66792 | 12625_6#76 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900081125 | 1280 | 63.89 | | ||
| 66792 | 12673_4#35 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082405 | 1280 | 63.73 | | ||
| 66792 | 12673_5#68 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082845 | 1280 | 63.3 | | ||
| 66792 | 12673_3#11 assembly for Staphylococcus aureus 2588STDY5748679 | scaffold | GCA_001289605 | 2703718923 | 1280 | 63.24 | | |
| 66792 | 12673_5#4 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082665 | 1280 | 61.91 | | ||
| 66792 | 12673_2#87 assembly for Staphylococcus aureus MRSA | scaffold | GCA_900082205 | 1280 | 60.8 | |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 124043 | Staphylococcus aureus strain ATCC 33592 16S ribosomal RNA gene, partial sequence. | MH173807 | 922 | | 1280 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Antimicrobial Activity of a Novel Cu(NO3)2-Containing Sol-Gel Surface under Different Testing Conditions. | Toplitsch D, Lackner JM, Schwan AM, Hinterer A, Stogmuller P, Horn K, Fritzlar N, Pfuch A, Kittinger C. | Materials (Basel) | 10.3390/ma14216488 | 2021 | | |
| Assessing Antimicrobial Efficacy on Plastics and Other Non-Porous Surfaces: A Closer Look at Studies Using the ISO 22196:2011 Standard. | Bento de Carvalho T, Barbosa JB, Teixeira P. | Biology (Basel) | 10.3390/biology13010059 | 2024 | | |
| Elevating Skincare Science: Grape Seed Extract Encapsulation for Dermatological Care. | Castro ML, Azevedo-Silva J, Valente D, Machado A, Ribeiro T, Ferreira JP, Pintado M, Ramos OL, Borges S, Baptista-Silva S. | Molecules | 10.3390/molecules29163717 | 2024 | | |
| Exploring Silk Sericin for Diabetic Wounds: An In Situ-Forming Hydrogel to Protect against Oxidative Stress and Improve Tissue Healing and Regeneration. | Baptista-Silva S, Bernardes BG, Borges S, Rodrigues I, Fernandes R, Gomes-Guerreiro S, Pinto MT, Pintado M, Soares R, Costa R, Oliveira AL. | Biomolecules | 10.3390/biom12060801 | 2022 | | |
| Enhanced Bioactivity of Tailor-Made Glycolipid Enriched Manuka Honey. | Delavault A, Zoheir AE, Muller D, Hollenbach R, Rabe KS, Ochsenreither K, Rudat J, Syldatk C. | Int J Mol Sci | 10.3390/ijms231912031 | 2022 | | |
| Cell-free biosynthesis combined with deep learning accelerates de novo-development of antimicrobial peptides. | Pandi A, Adam D, Zare A, Trinh VT, Schaefer SL, Burt M, Klabunde B, Bobkova E, Kushwaha M, Foroughijabbari Y, Braun P, Spahn C, Preusser C, Pogge von Strandmann E, Bode HB, von Buttlar H, Bertrams W, Jung AL, Abendroth F, Schmeck B, Hummer G, Vazquez O, Erb TJ. | Nat Commun | 10.1038/s41467-023-42434-9 | 2023 | | |
| Pathogenicity | Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial Infection. | Fraser-Pitt DJ, Mercer DK, Smith D, Kowalczuk A, Robertson J, Lovie E, Perenyi P, Cole M, Doumith M, Hill RLR, Hopkins KL, Woodford N, O'Neil DA. | Infect Immun | 10.1128/iai.00947-17 | 2018 | |
| Enzymology | Prevalence of types of methicillin-resistant Staphylococcus aureus in turkey flocks and personnel attending the animals. | Richter A, Sting R, Popp C, Rau J, Tenhagen BA, Guerra B, Hafez HM, Fetsch A. | Epidemiol Infect | 10.1017/s095026881200009x | 2012 | |
| Enzymology | Longitudinal development of the dust microbiome in a newly opened Norwegian kindergarten. | Nygaard AB, Charnock C. | Microbiome | 10.1186/s40168-018-0553-x | 2018 | |
| Pathogenicity | Antimicrobial compounds from marine actinomycetes. | Wang C, Lu Y, Cao S. | Arch Pharm Res | 10.1007/s12272-020-01251-0 | 2020 | |
| Role of flies as vectors of foodborne pathogens in rural areas. | Barreiro C, Albano H, Silva J, Teixeira P. | ISRN Microbiol | 10.1155/2013/718780 | 2013 | | |
| Enzymology | Methicillin-resistant Staphylococcus aureus screening by online immunometric monitoring of bacterial growth under selective pressure. | Stenholm T, Hakanen AJ, Vaarno J, Pihlasalo S, Terho P, Hanninen PE, Vuopio-Varkila J, Huovinen P, Kotilainen P. | Antimicrob Agents Chemother | 10.1128/aac.00518-09 | 2009 | |
| Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength. | Schastak S, Ziganshyna S, Gitter B, Wiedemann P, Claudepierre T. | PLoS One | 10.1371/journal.pone.0011674 | 2010 | | |
| Antimicrobial and anti-virulence activities of Mastoparan C and its derivatives against methicillin-resistant Staphylococcus aureus. | Nguyen TP, Phuong HBT, Thanh BNT, Giap HT, Xuan HL, Bui LM. | J Appl Microbiol | 10.1093/jambio/lxaf254 | 2025 | | |
| Comparative disinfectant sensitivity of methicillin-resistant and methicillin-sensitive Staphylococcus aureus cells. | Karcher R, Smith LS, Rastogi VK. | J Microbiol Methods | 10.1016/j.mimet.2025.107275 | 2025 | | |
| Synergistic activity of fosfomycin and flucloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus: in vitro and in vivo assessment. | Nussbaumer-Proll A, Obermuller M, Weiss-Tessbach M, Eberl S, Zeitlinger M, Matiba B, Mayer C, Kussmann M. | Med Microbiol Immunol | 10.1007/s00430-025-00841-3 | 2025 | | |
| Sequence Permutation Generated Lysine and Tryptophan-Rich Antimicrobial Peptides with Enhanced Therapeutic Index. | Peng KL, Wu YH, Hsu HC, Cheng JW. | Antibiotics (Basel) | 10.3390/antibiotics14111077 | 2025 | | |
| In Vitro Evaluation of Halotolerant Bacillus velezensis 24.5 as a Promising Probiotic with Broad-Spectrum Antimicrobial Activity. | Diguta FC, Toma RC, Matei F. | Microorganisms | 10.3390/microorganisms13102240 | 2025 | | |
| Susceptibility of Staphylococcus aureus to Anti-Inflammatory Drugs with a Focus on the Combinatory Effect of Celecoxib with Oxacillin In Vitro. | Okpala OE, Rondevaldova J, Osei-Owusu H, Kudera T, Kokoskova T, Kokoska L. | Molecules | 10.3390/molecules29153665 | 2024 | | |
| Molecular Differentiation and Detection of AMR Genes from Nosocomial Staphylococcus spp. | Carneiro I, da Silva WLP, de Souza Santos DR, de Filippis I. | Pathogens | 10.3390/pathogens14050403 | 2025 | | |
| Preparation and optimization of niosome encapsulated meropenem for significant antibacterial and anti-biofilm activity against methicillin-resistant Staphylococcus aureus isolates. | Paseban K, Noroozi S, Gharehcheloo R, Haddadian A, Falahi Robattorki F, Dibah H, Amani R, Sabouri F, Ghanbarzadeh E, Hajrasouiha S, Azari A, Rashidian T, Mirzaie A, Pirdolat Z, Salarkia M, Shahrava DS, Safaeinikjoo F, Seifi A, Sadat Hosseini N, Saeinia N, Bagheri Kashtali A, Ahmadiyan A, Mazid Abadi R, Sadat Kermani F, Andalibi R, Chitgarzadeh A, Tavana AA, Piri Gharaghie T. | Heliyon | 10.1016/j.heliyon.2024.e35651 | 2024 | | |
| The efficacy of the food-grade antimicrobial xanthorrhizol against Staphylococcus aureus is associated with McsL channel expression. | Mordukhova EA, Kim J, Jin H, No KT, Pan JG. | Front Microbiol | 10.3389/fmicb.2024.1439009 | 2024 | | |
| In Silico Approach for Antibacterial Discovery: PTML Modeling of Virtual Multi-Strain Inhibitors Against Staphylococcus aureus. | Kleandrova VV, Cordeiro MNDS, Speck-Planche A. | Pharmaceuticals (Basel) | 10.3390/ph18020196 | 2025 | | |
| In Vivo Effect of Halicin on Methicillin-Resistant Staphylococcus aureus-Infected Caenorhabditis elegans and Its Clinical Potential. | Kao LT, Yang TY, Hung WC, Yang WT, He P, Chen BX, Wang YC, Chen SS, Lai YW, Wang HY, Tseng SP. | Antibiotics (Basel) | 10.3390/antibiotics13090906 | 2024 | | |
| Functional Profiling of Enterococcus and Pediococcus Strains: An In Vitro Study on Probiotic and Postbiotic Properties. | Pristavu MC, Diguta FC, Aldea AC, Badea F, Dragoi Cudalbeanu M, Ortan A, Matei F. | Microorganisms | 10.3390/microorganisms13061348 | 2025 | | |
| Synthesis, Physicochemical Characterization, Antimicrobial Properties, and DFT/ADMET Calculations of Imidazolium-Based Ionic Liquids with a Homologous Series of Oxychlorine Anions. | Vranes MB, Capelja E, Karaman M, Borovic TT, Vukov A, Klimenta S, Rastija V, Selak JJ. | Molecules | 10.3390/molecules30224346 | 2025 | | |
| Molecular Investigation and Virulence Determination of Methicillin and Vancomycin Resistant Clinical Staphylococcus Aureus Isolates. | Eslamnezhad N, Ghandehari F, Mirzaee M, Mehrabi MR, Madani M. | Arch Razi Inst | 10.32592/ari.2025.80.1.209 | 2025 | | |
| Bioorthogonal probes for L-form conversion visualization and insights into antimicrobial resistance. | Tao Y, Feng Y, Peng Y, Wang X, Meng X, Xu Y, Han X, Zhang Q, Hu HY. | Chem Sci | 10.1039/d5sc01586c | 2025 | | |
| LL37-Derived Fragments Improve the Antibacterial Potential of Penicillin G and Ampicillin against Methicillin-Resistant Staphylococcus aureus. | Han W, Camesano TA. | Antibiotics (Basel) | 10.3390/antibiotics12091398 | 2023 | | |
| Biotechnology | Fabrication and antimicrobial properties of novel meropenem-honey encapsulated chitosan nanoparticles against multiresistant and biofilm-forming Staphylococcus aureus as a new antimicrobial agent. | Hajimohammadi S, Momtaz H, Tajbakhsh E. | Vet Med Sci | 10.1002/vms3.1440 | 2024 | |
| Preliminary osteogenic and antibacterial investigations of wood derived antibiotic-loaded bone substitute for the treatment of infected bone defects. | Salamanna F, De Luca A, Vandenbulcke F, Di Matteo B, Kon E, Grassi A, Ballardini A, Morozzi G, Raimondi L, Bellavia D, Costa V, Zaffagnini S, Fini M, Giavaresi G. | Front Bioeng Biotechnol | 10.3389/fbioe.2024.1412584 | 2024 | | |
| Antimicrobial Resistance Characterization of Methicillin-Resistant Staphylococcus aureus and Staphylococcus pseudintermedius Isolates from Clinical Cases in Dogs and Cats in Belgium. | Dewulf S, Boyen F, Paepe D, Clercx C, Tilman N, Dewulf J, Boland C. | Antibiotics (Basel) | 10.3390/antibiotics14070631 | 2025 | | |
| Activity of silver-zinc nanozeolite-based antibiofilm wound dressings in an in vitro biofilm model and comparison with commercial dressings. | Alobaid SA, Shrestha S, Tasseff M, Wang B, van Hoek ML, Dutta PK. | Discov Nano | 10.1186/s11671-025-04208-8 | 2025 | | |
| New Streptomyces-Derived Antibacterial Compounds Targeting Gram-Positive Bacteria: A Systematic Review. | Ait Assou S, El Hassouni M. | ScientificWorldJournal | 10.1155/tswj/6659874 | 2025 | | |
| Antibacterial Effects of Various Types of Bee Products in Malaysia: A Systematic Review. | Mohamad NA, Al-Emerieen AF, Irekeola AA, Shueb RH. | Malays J Med Sci | 10.21315/mjms2024.31.3.3 | 2024 | | |
| Biotechnology | Validation of the Peel Plate Staphylococcus Aureus (SA) Test for Enumeration of S. aureus in Selected Foods and Non-Cultured Dairy Products: AOAC Performance Tested MethodSM 082401. | Salter RS, Durbin GW, Li S, Gilbert M, Crowley ES, Deterding A, Bastin B. | J AOAC Int | 10.1093/jaoacint/qsae083 | 2025 | |
| Synthesis, Characterization, and Bioactivity of Mesoporous Bioactive Glass Codoped with Zinc and Silver. | Yang TY, Chern GI, Wang WH, Shih CJ. | Int J Mol Sci | 10.3390/ijms241813679 | 2023 | | |
| Geministatins: new depside antibiotics from the fungus Austroacremonium gemini. | Crombie A, Kalaitzis JA, Chen R, Vuong D, Lacey AE, Lacey E, Shivas RG, Tan YP, Sbaraini N, Chooi YH, Piggott AM. | J Antibiot (Tokyo) | 10.1038/s41429-024-00755-x | 2024 | | |
| Efficacy of lysostaphin-coated titanium plates on implant-associated MRSA osteitis in minipigs. | Jaekel C, Windolf CD, Bieler D, Oezel L, Seiler LF, Lakomek FN, Beyersdorf C, Mertens J, Steuwe A, Windolf J, Grassmann JP. | Eur J Trauma Emerg Surg | 10.1007/s00068-024-02448-4 | 2024 | | |
| In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. | Klose M, Weber L, Bachmann HS. | PLoS One | 10.1371/journal.pone.0331440 | 2025 | | |
| Diverse chemotypes of polyketides as promising antimicrobial agents: latest progress. | Kumar G, Chopra S. | RSC Adv | 10.1039/d5ra03414k | 2025 | | |
| The aquastatin biosynthetic gene cluster encodes a versatile polyketide synthase capable of synthesising heteromeric depsides with diverse alkyl side chains. | Sbaraini N, Crombie A, Kalaitzis JA, Vuong D, Bracegirdle J, Windsor F, Lau A, Chen R, Tan YP, Lacey A, Lacey E, Piggott AM, Chooi YH. | Chem Sci | 10.1039/d4sc05557h | 2024 | | |
| The Influence of Silver-Containing Bionanomaterials Based on Humic Ligands on Biofilm Formation in Opportunistic Pathogens. | Zykova MV, Karpova MR, Zhang Y, Chubik MV, Shunkova DM, Azarkina LA, Mihalyov DA, Konstantinov AI, Plotnikov EV, Pestryakov AN, Perminova IV, Belousov MV. | Nanomaterials (Basel) | 10.3390/nano14171453 | 2024 | | |
| Two-photon lithography for customized microstructured surfaces and their influence on wettability and bacterial load. | Zagiczek SN, Weiss-Tessbach M, Kussmann M, Moser D, Stoiber M, Moscato F, Schima H, Grasl C. | 3D Print Med | 10.1186/s41205-024-00211-4 | 2024 | | |
| Pathogenicity | Activating Thermoplastic Polyurethane Surfaces with Poly(ethylene glycol)-Based Recombinant Human alpha-Defensin 5 Monolayers for Antibiofilm Activity. | Rodriguez Rodriguez X, Lopez-Cano A, Mayolo-Deloisa K, Pich OQ, Bierge P, Ventosa N, Garcia-de-la-Maria C, Miro JM, Gasch O, Veciana J, Guasch J, Aris A, Garcia-Fruitos E, Ratera I, FUNCATH investigators. | ACS Appl Bio Mater | 10.1021/acsabm.4c00732 | 2025 | |
| Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model. | Kussmann M, Obermueller M, Karer M, Kriz R, Chen RY, Hohl L, Schneider L, Burgmann H, Traby L, Vossen MG. | Front Pharmacol | 10.3389/fphar.2021.685807 | 2021 | | |
| Quality improvement study on the effectiveness of intranasal povidone-iodine decolonization on surgery patients. | Hammond EN, Kates AE, Putman-Buehler N, Watson L, Godfrey JJ, Riley CN, Dixon J, Brys N, Haleem A, Bentz ML, Safdar N. | Infect Prev Pract | 10.1016/j.infpip.2023.100274 | 2023 | | |
| Enzymology | Enzymatic Activity Profiling Using an Ultrasensitive Array of Chemiluminescent Probes for Bacterial Classification and Characterization. | Shelef O, Kopp T, Tannous R, Arutkin M, Jospe-Kaufman M, Reuveni S, Shabat D, Fridman M. | J Am Chem Soc | 10.1021/jacs.3c11790 | 2024 | |
| Exploring the Potential of Torulaspora delbrueckii, Starmerella bacillaris, and Saccharomyces cerevisiae as a Probiotic Starter for Craft Beer Production. | Vrinceanu CR, Diguta FC, Cudalbeanu MD, Ortan A, Mihai C, Barbulescu ID, Frincu M, Begea M, Matei F, Teodorescu RI. | Foods | 10.3390/foods14091608 | 2025 | | |
| A new application of avocado oil to enrich the biological activities of polycaprolactone membranes for tissue engineering. | Yurtsever MC, Aydogan S, Iyigundogdu Z, Comertpay A, Demir D, Ceylan S. | Biopolymers | 10.1002/bip.23617 | 2024 | | |
| Do Different Sutures with Triclosan Have Different Antimicrobial Activities? A Pharmacodynamic Approach. | Daoud FC, M'Zali F, Zabala A, Moore N, Rogues AM. | Antibiotics (Basel) | 10.3390/antibiotics11091195 | 2022 | | |
| Arzanol: A Review of Chemical Properties and Biological Activities. | Voynikov Y. | Plants (Basel) | 10.3390/plants14223474 | 2025 | | |
| Disinfection of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium and Acinetobacter baumannii using Klaran WD array system. | Mariita RM, Randive RV. | Access Microbiol | 10.1099/acmi.0.000194 | 2021 | | |
| Wettability of Amino Acid-Functionalized PSMA Electrospun Fibers for the Modulated Release of Active Agents and Its Effect on Their Bioactivity. | Santander S, Padilla-Manzano N, Diaz B, Bacchiega R, Jara E, Alvarez LF, Pinto C, Forero JC, Santana P, Hamm E, Urzua M, Tamayo L. | Pharmaceutics | 10.3390/pharmaceutics15061659 | 2023 | | |
| Disinfection of needleless connectors for catheters in one second using a hand-held UV device. | Fourkas M, Takami E, Schears GJ, Farr-Jones S, Rasooly J. | Am J Infect Control | 10.1016/j.ajic.2024.03.017 | 2024 | | |
| Evaluation of Antibacterial Effects of Matrix-Induced Silver Ions against Antibiotic-Resistant ESKAPE Pathogens. | Huang YC, Yang TY, Chen BX, Kung JC, Shih CJ. | Pharmaceuticals (Basel) | 10.3390/ph14111094 | 2021 | | |
| Limosilactobacillus fermentum 3872 That Produces Class III Bacteriocin Forms Co-Aggregates with the Antibiotic-Resistant Staphylococcus aureus Strains and Induces Their Lethal Damage. | Abramov VM, Kosarev IV, Machulin AV, Priputnevich TV, Deryusheva EI, Nemashkalova EL, Chikileva IO, Abashina TN, Panin AN, Melnikov VG, Suzina NE, Nikonov IN, Selina MV, Khlebnikov VS, Sakulin VK, Samoilenko VA, Gordeev AB, Sukhikh GT, Uversky VN, Karlyshev AV. | Antibiotics (Basel) | 10.3390/antibiotics12030471 | 2023 | | |
| In vitro activity of selected antimicrobials against methicillin-resistant Staphylococcus pseudintermedius of canine origin in Poland. | Kizerwetter-Swida M, Chrobak-Chmiel D, Stefanska I, Kwiecien E, Rzewuska M. | Vet Med Sci | 10.1002/vms3.1385 | 2024 | | |
| In vitro and in silico prediction of antibacterial interaction between essential oils via graph embedding approach. | Yabuuchi H, Hayashi K, Shigemoto A, Fujiwara M, Nomura Y, Nakashima M, Ogusu T, Mori M, Tokumoto SI, Miyai K. | Sci Rep | 10.1038/s41598-023-46377-5 | 2023 | | |
| Recent advances in the use of resveratrol against Staphylococcus aureus infections (Review). | Cui W, Wang Y, Zhang L, Liu F, Duan G, Chen S, Long J, Jin Y, Yang H. | Med Int (Lond) | 10.3892/mi.2024.191 | 2024 | | |
| SF5- and SCF3-substituted tetrahydroquinoline compounds as potent bactericidal agents against multidrug-resistant persister Gram-positive bacteria. | Onyedibe KI, Dayal N, Sintim HO. | RSC Med Chem | 10.1039/d1md00211b | 2021 | | |
| Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. | Sionov RV, Steinberg D. | Biomedicines | 10.3390/biomedicines10030631 | 2022 | | |
| Pathogenicity | Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus. | Feldman M, Smoum R, Mechoulam R, Steinberg D. | PLoS One | 10.1371/journal.pone.0231583 | 2020 | |
| Antimicrobial Activity of Eco-Friendly Fly-Ash-Based Geopolymer Mortar. | Iyigundogdu Z, Urunveren H, Beycioglu A, Ibadov N. | Materials (Basel) | 10.3390/ma18081735 | 2025 | | |
| Bisindole Compounds-Synthesis and Medicinal Properties. | Marinescu M. | Antibiotics (Basel) | 10.3390/antibiotics13121212 | 2024 | | |
| Pathogenicity | Structure-Antimicrobial Activity Relationships of Recombinant Host Defence Peptides Against Drug-Resistant Bacteria. | Trave-Asensio S, Tort-Miro A, Pinheiro S, Garcia-Fruitos E, Aris A, Zamora WJ. | Microb Biotechnol | 10.1111/1751-7915.70204 | 2025 | |
| A combination therapy strategy for treating antibiotic resistant biofilm infection using a guanidinium derivative and nanoparticulate Ag(0) derived hybrid gel conjugate. | Dey A, Yadav M, Kumar D, Dey AK, Samal S, Tanwar S, Sarkar D, Pramanik SK, Chaudhuri S, Das A. | Chem Sci | 10.1039/d2sc02980d | 2022 | | |
| Suertides A-C: selective antibacterial cyclic hexapeptides from Amycolatopsis sp. MST-135876v3. | Lacey HJ, Chen R, Vuong D, Fisher MF, Lacey E, Rutledge PJ, Piggott AM. | J Antibiot (Tokyo) | 10.1038/s41429-022-00544-4 | 2022 | | |
| Lipoteichoic Acid Biosynthesis Inhibitors as Potent Inhibitors of S. aureus and E. faecalis Growth and Biofilm Formation. | Naclerio GA, Onyedibe KI, Sintim HO. | Molecules | 10.3390/molecules25102277 | 2020 | | |
| Phenanthrenes from Juncus articulatus with Antibacterial and Biofilm Formation Inhibitory Activity. | Barta A, Salusso A, Kusz N, Berkecz R, Schlauer J, Purger D, Hohmann J, Carpinella MC, Vasas A. | J Nat Prod | 10.1021/acs.jnatprod.4c00577 | 2024 | | |
| Isoquinoline Antimicrobial Agent: Activity against Intracellular Bacteria and Effect on Global Bacterial Proteome. | Karanja CW, Naganna N, Abutaleb NS, Dayal N, Onyedibe KI, Aryal U, Seleem MN, Sintim HO. | Molecules | 10.3390/molecules27165085 | 2022 | | |
| Ab initio Designed Antimicrobial Peptides Against Gram-Negative Bacteria. | Bobde SS, Alsaab FM, Wang G, Van Hoek ML. | Front Microbiol | 10.3389/fmicb.2021.715246 | 2021 | | |
| Anti-inflammatory coupled anti-angiogenic airway stent effectively suppresses tracheal in-stents restenosis. | Zhao Y, Liu Y, Shan J, Xu X, Zhang C, Liu Z, Li X, Zhong Z, Gao Y, Ren K, Jiao D, Ren J, Wu P, Jiang Y, Han X. | J Nanobiotechnology | 10.1186/s12951-024-03087-y | 2025 | | |
| Potent trifluoromethoxy, trifluoromethylsulfonyl, trifluoromethylthio and pentafluorosulfanyl containing (1,3,4-oxadiazol-2-yl)benzamides against drug-resistant Gram-positive bacteria. | Naclerio GA, Abutaleb NS, Onyedibe KI, Seleem MN, Sintim HO. | RSC Med Chem | 10.1039/c9md00391f | 2020 | | |
| Studies Regarding Antimicrobial Properties of Some Microbial Polyketides Derived from Monascus Strains. | Albisoru D, Radu N, Pirvu LC, Stefaniu A, Babeanu N, Stoica R, Mihai DP. | Antibiotics (Basel) | 10.3390/antibiotics13111092 | 2024 | | |
| UV-C side-emitting optical fiber-based disinfection: a promising approach for infection control in tight channels. | Mohsin MS, Avdic M, Fitzpatrick K, Lanzarini-Lopes M. | Microbiol Spectr | 10.1128/spectrum.00040-24 | 2024 | | |
| Antimicrobial effects of syndiotactic polypeptides. | Hazam PK, Phukan C, Akhil R, Singh A, Ramakrishnan V. | Sci Rep | 10.1038/s41598-021-81394-2 | 2021 | | |
| Synergistic antifungal activity of lepidium sativum ZnO nanoparticles and nystatin against resistant candida species. | Yassin MT, Mohamed S, Al-Otibi FO, Maniah K, AbdelGawwad MR. | Sci Rep | 10.1038/s41598-025-20233-0 | 2025 | | |
| Antimicrobial and Methicillin Resistance Pattern of Potential Mastitis-Inducing Staphylococcus aureus and Coagulase-Negative Staphylococci Isolates from the Mammary Secretion of Dairy Goats. | Nelli A, Voidarou CC, Venardou B, Fotou K, Tsinas A, Bonos E, Fthenakis GC, Skoufos I, Tzora A. | Biology (Basel) | 10.3390/biology11111591 | 2022 | | |
| Polyglactin 910 Meshes Coated with Sustained-Release Cannabigerol Varnish Inhibit Staphylococcus aureus Biofilm Formation and Macrophage Cytokine Secretion: An In Vitro Study. | Abudalu M, Aqawi M, Sionov RV, Friedman M, Gati I, Munz Y, Ohana G, Steinberg D. | Pharmaceuticals (Basel) | 10.3390/ph16050745 | 2023 | | |
| Prevalence of mecA and Panton-Valentine Leukocidin Genes in Staphylococcus aureus Clinical Isolates from Gaza Strip Hospitals. | El Aila NA, Al Laham NA, Naas T. | Microorganisms | 10.3390/microorganisms11051155 | 2023 | | |
| Laboratory-based study of novel antimicrobial cold spray coatings to combat surface microbial contamination. | Lucas MDI, Botef I, Reid RG, van Vuuren SF. | Infect Control Hosp Epidemiol | 10.1017/ice.2020.335 | 2020 | | |
| Impregnation of Melaleuca Family Essential Oil Nanoemulsions into Pectin:Polyvinyl Alcohol Patches to Provide an Antibacterial Environment for Infected Wounds. | Demir D, Ceylan S, Ipek SL, Aslan D, Ozbolat V. | ChemistryOpen | 10.1002/open.202500117 | 2025 | | |
| Detection of Genes Encoding Microbial Surface Component Recognizing Adhesive Matrix Molecules in Methicillin-Resistant Staphylococcus aureus Isolated from Pyoderma Patients. | Alorabi M, Ejaz U, Khoso BK, Uddin F, Mahmoud SF, Sohail M, Youssef M. | Genes (Basel) | 10.3390/genes14040783 | 2023 | | |
| Gossypol acetate: A natural polyphenol derivative with antimicrobial activities against the essential cell division protein FtsZ. | Du RL, Chow HY, Chen YW, Chan PH, Daniel RA, Wong KY. | Front Microbiol | 10.3389/fmicb.2022.1080308 | 2022 | | |
| Enhanced biocidal efficacy of alcohol based disinfectants with salt additives. | Oh E, Shin H, Han S, Do SJ, Shin Y, Pi JH, Kim Y, Ko DH, Lee KH, Choi HJ. | Sci Rep | 10.1038/s41598-025-87811-0 | 2025 | | |
| A Cell-Free Screen for Bacterial Membrane Disruptors Identifies Mefloquine as a Novel Antibiotic Adjuvant. | Podoll J, Olson J, Wang W, Wang X. | Antibiotics (Basel) | 10.3390/antibiotics10030315 | 2021 | | |
| The Biotechnological Potential of Pediococcus spp. Isolated from Kombucha Microbial Consortium. | Diguta CF, Nitoi GD, Matei F, Luta G, Cornea CP. | Foods | 10.3390/foods9121780 | 2020 | | |
| Novel pentafluorosulfanyl-containing triclocarban analogs selectively kill Gram-positive bacteria. | Pormohammad A, Moradi M, Hommes JW, Pujol E, Naesens L, Vazquez S, Surewaard BGJ, Zarei M, Vazquez-Carrera M, Turner RJ. | Microbiol Spectr | 10.1128/spectrum.00071-24 | 2024 | | |
| Biosynthesis of Cytosporones in Leotiomycetous Filamentous Fungi. | Li L, Zhong W, Liu H, Espinosa-Artiles P, Xu YM, Wang C, Verdugo Robles JM, Paz TA, Cascaes Inacio M, Chen F, Xu Y, Gunatilaka AAL, Molnar I. | J Am Chem Soc | 10.1021/jacs.3c14066 | 2024 | | |
| Pathogenicity | Novel pyrazoles as potent growth inhibitors of staphylococci, enterococci and Acinetobacter baumannii bacteria. | Alkhaibari I, Kc HR, Angappulige DH, Gilmore D, Alam MA. | Future Med Chem | 10.4155/fmc-2021-0140 | 2022 | |
| Impact of pharmacokinetic enhancement strategies on the antimicrobial and antioxidant activities of hydroxytyrosol. | Prevete G, Scipioni E, Donati E, Villanova N, Fochetti A, Lilla L, Borocci S, Bernini R, Mazzonna M. | RSC Adv | 10.1039/d4ra08205b | 2025 | | |
| Endophytic Bacteria Enterobacter hormaechei Fabricated Silver Nanoparticles and Their Antimicrobial Activity. | Monowar T, Rahman MS, Bhore SJ, Sathasivam KV. | Pharmaceutics | 10.3390/pharmaceutics13040511 | 2021 | | |
| Enzymology | Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis. | van Os W, Wulkersdorfer B, Eberl S, Oesterreicher Z, Schwabl P, Reiberger T, Paternostro R, Weber M, Willinger B, Zeitlinger M. | Front Pharmacol | 10.3389/fphar.2023.1124821 | 2023 | |
| Multilayer Electrospun Scaffolds of Opposite-Charged Chitosans. | Balducci C, Roso M, Zamuner A, Falcigno L, D'Auria G, Brun P, Dettin M. | Int J Mol Sci | 10.3390/ijms25063256 | 2024 | | |
| Metabolism | Mechanism of Azalomycin F5a against Methicillin-Resistant Staphylococcus aureus. | Xu L, Xu X, Yuan G, Wang Y, Qu Y, Liu E. | Biomed Res Int | 10.1155/2018/6942452 | 2018 | |
| Successful Removal of Clostridioides Difficile Spores and Pathogenic Bacteria From a Launderable Barrier Using a Commercial Laundry Process. | Hooker EA, Ulrich D, Brooks D. | Infect Dis (Auckl) | 10.1177/1178633720923657 | 2020 | | |
| Design, synthesis, and antibacterial activity of N-(trifluoromethyl)phenyl substituted pyrazole derivatives. | Saleh I, Raj Kc H, Roy S, Abugazleh MK, Ali H, Gilmore D, Alam MA. | RSC Med Chem | 10.1039/d1md00230a | 2021 | | |
| Antibacterial and Anti-Inflammatory Potential of Polyherbal Formulation Used in Chronic Wound Healing. | Mandrika I, Kumar S, Zandersone B, Eranezhath SS, Petrovska R, Liduma I, Jezupovs A, Pirags V, Tracevska T. | Evid Based Complement Alternat Med | 10.1155/2021/9991454 | 2021 | | |
| Thiazolation of phenylthiosemicarbazone to access new thiazoles: anticancer activity and molecular docking. | Elgammal WE, Shaban SS, Eliwa EM, Halawa AH, Abd El-Gilil SM, Hassan RA, Abdou AM, Elhagali GA, Reheim MA. | Future Med Chem | 10.1080/17568919.2024.2342668 | 2024 | | |
| Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications. | Shleeva MO, Kondratieva DA, Kaprelyants AS. | Pharmaceutics | 10.3390/pharmaceutics15071893 | 2023 | | |
| Promising Probiotic Properties of the Yeasts Isolated from Rabilé, a Traditionally Fermented Beer Produced in Burkina Faso. | Mogmenga I, Somda MK, Ouattara CAT, Keita I, Dabire Y, Diguta CF, Toma RC, Ezeogu LI, Ugwuanyi JO, Ouattara AS, Matei F. | Microorganisms | 10.3390/microorganisms11030802 | 2023 | | |
| Treatment of Clinically Important Bacteria With Cold Atmospheric Plasma. | Ding R, Song J, Huang X, Tan L, Rao X, Yang Y. | Microb Biotechnol | 10.1111/1751-7915.70219 | 2025 | | |
| Pathogenicity | Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus. | Alnufaie R, Alsup N, Kc HR, Newman M, Whitt J, Chambers SA, Gilmore D, Alam MA. | J Antibiot (Tokyo) | 10.1038/s41429-020-0341-2 | 2020 | |
| Pathogenicity | A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins. | Lopez-Cano A, Ferrer-Miralles N, Sanchez J, Carratala JV, Rodriguez XR, Ratera I, Guasch J, Pich OQ, Bierge P, Garcia-de-la-Maria C, Miro JM, Garcia-Fruitos E, Aris A, FUNCATH Investigators. | Pharmaceutics | 10.3390/pharmaceutics15041068 | 2023 | |
| Validation of Qualitative Broth Volatilization Checkerboard Method for Testing of Essential Oils: Dual-Column GC-FID/MS Analysis and In Vitro Combinatory Antimicrobial Effect of Origanum vulgare and Thymus vulgaris against Staphylococcus aureus in Liquid and Vapor Phases. | Netopilova M, Houdkova M, Urbanova K, Rondevaldova J, Kokoska L. | Plants (Basel) | 10.3390/plants10020393 | 2021 | | |
| The Practical Utility of Imidazolium Hydrogen Sulfate Ionic Liquid in Fabrication of Lignin-Based Spheres: Structure Characteristic and Antibacterial Activity. | Stanisz M, Klapiszewski L, Dobrowolska A, Piasecki A, Czaczyk K, Jesionowski T. | Front Chem | 10.3389/fchem.2022.946665 | 2022 | | |
| Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors. | Roy S, Kc HR, Roberts J, Hastings J, Gilmore DF, Shields RC, Alam MA. | J Med Chem | 10.1021/acs.jmedchem.3c00969 | 2023 | | |
| Corneal cross-linking guards against infectious keratitis: an experimental model. | Marrie A, Abdullatif AM, Gamal El Dine S, Yehia R, Saied R, Tolba DA. | Int Ophthalmol | 10.1007/s10792-022-02522-z | 2023 | | |
| Thermoplastic elastomers containing antimicrobial and antiviral additives for mobility applications. | Iyigundogdu Z, Basar B, Couvreur R, Tamrakar S, Yoon J, Ersoy OG, Sahin F, Mielewski D, Kiziltas A. | Compos B Eng | 10.1016/j.compositesb.2022.110060 | 2022 | | |
| Design Guidelines for Cationic Pillar[n]arenes that Prevent Biofilm Formation by Gram-Positive Pathogens. | Kaizerman-Kane D, Hadar M, Joseph R, Logviniuk D, Zafrani Y, Fridman M, Cohen Y. | ACS Infect Dis | 10.1021/acsinfecdis.0c00662 | 2021 | | |
| Metabolism | Selection of sponge-associated bacteria with high potential for the production of antibacterial compounds. | Riyanti, Balansa W, Liu Y, Sharma A, Mihajlovic S, Hartwig C, Leis B, Rieuwpassa FJ, Ijong FG, Wagele H, Konig GM, Schaberle TF. | Sci Rep | 10.1038/s41598-020-76256-2 | 2020 | |
| Same-day antimicrobial susceptibility test using acoustic-enhanced flow cytometry visualized with supervised machine learning. | Inglis TJJ, Paton TF, Kopczyk MK, Mulroney KT, Carson CF. | J Med Microbiol | 10.1099/jmm.0.001092 | 2020 | | |
| Small Schiff Base Molecules-A Possible Strategy to Combat Biofilm-Related Infections. | Coanda M, Limban C, Nuta DC. | Antibiotics (Basel) | 10.3390/antibiotics13010075 | 2024 | | |
| Antibacterial activity of a short de novo designed peptide against fish bacterial pathogens. | Bhat RAH, Khangembam VC, Pant V, Tandel RS, Pandey PK, Thakuria D. | Amino Acids | 10.1007/s00726-024-03388-4 | 2024 | | |
| In Situ Monitoring of the Antibacterial Activity of a Copper-Silver Alloy Using Confocal Laser Scanning Microscopy and pH Microsensors. | Ciacotich N, Kragh KN, Lichtenberg M, Tesdorpf JE, Bjarnsholt T, Gram L. | Glob Chall | 10.1002/gch2.201900044 | 2019 | | |
| Optimization of Anthocyanin Production in Tobacco Cells. | Carpi A, Rahim MA, Marin A, Armellin M, Brun P, Miotto G, Dal Monte R, Trainotti L. | Int J Mol Sci | 10.3390/ijms241813711 | 2023 | | |
| Pathogenicity | Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents. | Alnufaie R, Raj Kc H, Alsup N, Whitt J, Andrew Chambers S, Gilmore D, Alam MA. | Molecules | 10.3390/molecules25122758 | 2020 | |
| Antibiotic-Producing Beneficial Bacteria in the Gut of the Burying Beetle Nicrophorus vespilloides. | Heise P, Liu Y, Degenkolb T, Vogel H, Schaberle TF, Vilcinskas A. | Front Microbiol | 10.3389/fmicb.2019.01178 | 2019 | | |
| Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant Bacteria. | Whitt J, Duke C, Ali MA, Chambers SA, Khan MMK, Gilmore D, Alam MA. | ACS Omega | 10.1021/acsomega.9b01967 | 2019 | | |
| Pathogenicity | Antimicrobial and anti-biofilm activity of hexadentated macrocyclic complex of copper (II) derived from thiosemicarbazide against Staphylococcus aureus. | Brahma U, Kothari R, Sharma P, Bhandari V. | Sci Rep | 10.1038/s41598-018-26483-5 | 2018 | |
| Lactobacillus Strains for Vegetable Juice Fermentation-Quality and Health Aspects. | Voaides C, Boiu-Sicuia O, Israel-Roming F, Zamfir M, Grosu-Tudor SS, Angelescu IR, Cornea CP. | Biomedicines | 10.3390/biomedicines10112867 | 2022 | | |
| Pathogenicity | Antibacterial and anti-Trichomonas Vaginalis effects of Rosa Damascena mill petal oil (a persian medicine product), aqueous and hydroalcoholic extracts. | Saghafi F, Mirzaie F, Gorji E, Nabimeybodi R, Fattahi M, Mahmoodian H, Zareshahi R. | BMC Complement Med Ther | 10.1186/s12906-021-03434-8 | 2021 | |
| Microwave assisted synthesis of negative-charge carbon dots with potential antibacterial activity against multi-drug resistant bacteria. | Kung JC, Tseng IT, Chien CS, Lin SH, Wang CC, Shih CJ. | RSC Adv | 10.1039/d0ra07106d | 2020 | | |
| Pathogenicity | Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant Staphylococcus aureus and Acinetobacter baumannii. | Whitt J, Duke C, Sumlin A, Chambers SA, Alnufaie R, Gilmore D, Fite T, Basnakian AG, Alam MA. | Molecules | 10.3390/molecules24112051 | 2019 | |
| Enhancing outer membrane permeability of tetracycline antibiotics in P. aeruginosa using TOB-CIP conjugates. | Dhiman S, Ramirez D, Arora R, Arthur G, Schweizer F. | RSC Med Chem | 10.1039/d4md00329b | 2024 | | |
| Phyto-Mediated Copper Oxide Nanoparticles for Antibacterial, Antioxidant and Photocatalytic Performances. | Ssekatawa K, Byarugaba DK, Angwe MK, Wampande EM, Ejobi F, Nxumalo E, Maaza M, Sackey J, Kirabira JB. | Front Bioeng Biotechnol | 10.3389/fbioe.2022.820218 | 2022 | | |
| Antimicrobial Activity of Two Garlic Species (Allium Sativum and A. Tuberosum) Against Staphylococci Infection. In Vivo Study in Rats. | Venancio PC, Raimundo Figueroba S, Dias Nani B, Eduardo Nunes Ferreira L, Vilela Muniz B, de Sa Del Fiol F, Sartoratto A, Antonio Ribeiro Rosa E, Carlos Groppo F. | Adv Pharm Bull | 10.15171/apb.2017.015 | 2017 | | |
| Development of 4-[4-(Anilinomethyl)-3-phenyl-pyrazol-1-yl] Benzoic Acid Derivatives as Potent Anti-Staphylococci and Anti-Enterococci Agents. | Raj Kc H, Gilmore DF, Alam MA. | Antibiotics (Basel) | 10.3390/antibiotics11070939 | 2022 | | |
| Green Biofabrication of Silver Nanoparticles of Potential Synergistic Activity with Antibacterial and Antifungal Agents against Some Nosocomial Pathogens. | Al-Otibi FO, Yassin MT, Al-Askar AA, Maniah K. | Microorganisms | 10.3390/microorganisms11040945 | 2023 | | |
| Drastic Reduction of Bacterial, Fungal and Viral Pathogen Titers by Cuprous Oxide Impregnated Medical Textiles. | Borkow G, Salvatori R, Kanmukhla VK. | J Funct Biomater | 10.3390/jfb12010009 | 2021 | | |
| Pathogenicity | Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii. | Barksdale SM, Hrifko EJ, Chung EM, van Hoek ML. | BMC Microbiol | 10.1186/s12866-016-0799-z | 2016 | |
| Antibacterial potential of chalcones and its derivatives against Staphylococcus aureus. | da Silva L, Donato IA, Goncalves CAC, Scherf JR, Dos Santos HS, Mori E, Coutinho HDM, da Cunha FAB. | 3 Biotech | 10.1007/s13205-022-03398-7 | 2023 | | |
| Pathogenicity | In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus. | Lalouckova K, Skrivanova E, Rondevaldova J, Frankova A, Soukup J, Kokoska L. | Sci Rep | 10.1038/s41598-020-80481-0 | 2021 | |
| Sensitivity of Staphylococcal Biofilm to Selected Compounds of Plant Origin. | Swolana D, Kepa M, Kabala-Dzik A, Dzik R, Wojtyczka RD. | Antibiotics (Basel) | 10.3390/antibiotics10050607 | 2021 | | |
| In Vitro Evaluation of Biological Activities and Phytochemical Analysis of Different Solvent Extracts of Punica granatum L. (Pomegranate) Peels. | Yassin MT, Mostafa AA, Al Askar AA. | Plants (Basel) | 10.3390/plants10122742 | 2021 | | |
| Pathogenicity | Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain. | Lopez-Cano A, Martinez-Miguel M, Guasch J, Ratera I, Aris A, Garcia-Fruitos E. | Microb Cell Fact | 10.1186/s12934-022-01803-7 | 2022 | |
| Rhamnolipid-Coated Iron Oxide Nanoparticles as a Novel Multitarget Candidate against Major Foodborne E. coli Serotypes and Methicillin-Resistant S. aureus. | Sharaf M, Sewid AH, Hamouda HI, Elharrif MG, El-Demerdash AS, Alharthi A, Hashim N, Hamad AA, Selim S, Alkhalifah DHM, Hozzein WN, Abdalla M, Saber T. | Microbiol Spectr | 10.1128/spectrum.00250-22 | 2022 | | |
| Hydrothermally Assisted Fabrication of TiO2-Fe3O4 Composite Materials and Their Antibacterial Activity. | Kubiak A, Kubacka M, Gabala E, Dobrowolska A, Synoradzki K, Siwinska-Ciesielczyk K, Czaczyk K, Jesionowski T. | Materials (Basel) | 10.3390/ma13214715 | 2020 | | |
| A review on quinoline derivatives as anti-methicillin resistant Staphylococcus aureus (MRSA) agents. | Kumar P. | BMC Chem | 10.1186/s13065-020-00669-3 | 2020 | | |
| Enzymology | In-vitro release pharmacokinetics of amikacin, teicoplanin and polyhexanide in a platelet rich fibrin-layer (PRF)-a laboratory evaluation of a modern, autologous wound treatment. | Knafl D, Thalhammer F, Vossen MG. | PLoS One | 10.1371/journal.pone.0181090 | 2017 | |
| Conjugates of Aminoglycosides with Stapled Peptides as a Way to Target Antibiotic-Resistant Bacteria. | Macyszyn J, Burmistrz M, Mieczkowski A, Wojciechowska M, Trylska J. | ACS Omega | 10.1021/acsomega.3c02071 | 2023 | | |
| Decreased expression of femXAB genes and fnbp mediated biofilm pathways in OS-MRSA clinical isolates. | Brahma U, Sharma P, Murthy S, Sharma S, Chakraborty S, Appalaraju SN, Bhandari V. | Sci Rep | 10.1038/s41598-019-52557-z | 2019 | | |
| Diastereoselective synthesis and biological evaluation of enantiomerically pure tricyclic indolines. | He W, Griffiths BM, Wang W, Wang X. | Org Biomol Chem | 10.1039/c7ob00897j | 2017 | | |
| A Critical Review of Short Antimicrobial Peptides from Scorpion Venoms, Their Physicochemical Attributes, and Potential for the Development of New Drugs. | Fong-Coronado PA, Ramirez V, Quintero-Hernandez V, Balleza D. | J Membr Biol | 10.1007/s00232-024-00315-2 | 2024 | | |
| Polyphenol-Rich Larix decidua Bark Extract with Antimicrobial Activity against Respiratory-Tract Pathogens: A Novel Bioactive Ingredient with Potential Pharmaceutical and Nutraceutical Applications. | Faggian M, Bernabe G, Ferrari S, Francescato S, Baratto G, Castagliuolo I, Dall'Acqua S, Peron G. | Antibiotics (Basel) | 10.3390/antibiotics10070789 | 2021 | | |
| Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines. | Suaifan GARY, Mohammed AAM, Alkhawaja BA. | Molecules | 10.3390/molecules27051658 | 2022 | | |
| Intelligent electrospinning nanofibrous membranes for monitoring and promotion of the wound healing. | Qu Z, Wang Y, Dong Y, Li X, Hao L, Sun L, Zhou L, Jiang R, Liu W. | Mater Today Bio | 10.1016/j.mtbio.2024.101093 | 2024 | | |
| Discovery of FtsZ inhibitors by virtual screening as antibacterial agents and study of the inhibition mechanism. | Du RL, Sun N, Fung YH, Zheng YY, Chen YW, Chan PH, Wong WL, Wong KY. | RSC Med Chem | 10.1039/d1md00249j | 2022 | | |
| Pathogenicity | Ex vivo anti-microbial efficacy of various formaldehyde releasers against antibiotic resistant and antibiotic sensitive microorganisms involved in infectious keratitis. | Amponin DE, Przybek-Skrzypecka J, Zyablitskaya M, Takaoka A, Suh LH, Nagasaki T, Trokel SL, Paik DC. | BMC Ophthalmol | 10.1186/s12886-020-1306-8 | 2020 | |
| A niclosamide-tobramycin hybrid adjuvant potentiates cefiderocol against P. aeruginosa. | Berry L, Brizuela M, Jackson G, Schweizer F. | RSC Med Chem | 10.1039/d1md00206f | 2021 | | |
| Pathogenicity | Pillararenes as Promising Carriers for Drug Delivery. | Zyryanov GV, Kopchuk DS, Kovalev IS, Santra S, Majee A, Ranu BC. | Int J Mol Sci | 10.3390/ijms24065167 | 2023 | |
| Pathogenicity | Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus with Ru(II)-based type I/type II photosensitizers. | Arenas Y, Monro S, Shi G, Mandel A, McFarland S, Lilge L. | Photodiagnosis Photodyn Ther | 10.1016/j.pdpdt.2013.07.001 | 2013 | |
| Antibacterial and Antibiofilm Activities of Psychorubrin, a Pyranonaphthoquinone Isolated From Mitracarpus frigidus (Rubiaceae). | Lemos ASO, Campos LM, Melo L, Guedes MCMR, Oliveira LG, Silva TP, Melo RCN, Rocha VN, Aguiar JAK, Apolonio ACM, Scio E, Fabri RL. | Front Microbiol | 10.3389/fmicb.2018.00724 | 2018 | | |
| Synergistic Anticandidal Activities of Greenly Synthesized ZnO Nanomaterials with Commercial Antifungal Agents against Candidal Infections. | Yassin MT, Elgorban AM, Al-Askar AA, Sholkamy EN, Ameen F, Maniah K. | Micromachines (Basel) | 10.3390/mi14010209 | 2023 | | |
| Epoxy Isonitriles, A Unique Class of Antibiotics: Synthesis of Their Metabolites and Biological Investigations. | Ernouf G, Wilt IK, Zahim S, Wuest WM. | Chembiochem | 10.1002/cbic.201800550 | 2018 | | |
| Pathogenicity | Synthesis of Chimeric Thiazolo-Nootkatone Derivatives as Potent Antimicrobial Agents. | Alkhaibari IS, Raj K C H, Alnufaie R, Gilmore D, Alam MA. | ChemMedChem | 10.1002/cmdc.202100230 | 2021 | |
| Pathogenicity | Decolonization potential of 0.02% polyhexanide irrigation solution in urethral catheters under practice-like in vitro conditions. | Brill FHH, Gabriel H, Brill H, Klock JH, Steinmann J, Arndt A. | BMC Urol | 10.1186/s12894-018-0362-3 | 2018 | |
| Pathogenicity | Design and Synthesis of Malonamide Derivatives as Antibiotics against Methicillin-Resistant Staphylococcus aureus. | Su JC, Huang YT, Chen CS, Chiu HC, Shiau CW. | Molecules | 10.3390/molecules23010027 | 2017 | |
| Rational approaches towards inorganic and organometallic antibacterials. | Hess J. | Biol Chem | 10.1515/hsz-2021-0253 | 2022 | | |
| Direct detection of methicillin-resistant Staphylococcus aureus in sputum specimens from patients with hospital-associated pneumonia using a novel multilocus PCR assay. | Huang ZG, Zheng XZ, Guan J, Xiao SN, Zhuo C. | Pathogens | 10.3390/pathogens4020199 | 2015 | | |
| Pathogenicity | Influence of different peritoneal dialysis fluids on the in vitro activity of fosfomycin against Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa. | Kussmann M, Hauer S, Pichler P, Reznicek G, Burgmann H, Poeppl W, Zeitlinger M, Wiesholzer M. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-018-3221-y | 2018 | |
| Lactococcus Lactis Strain A5 Producing Nisin-like Bacteriocin Active against Gram Positive and Negative Bacteria. | Azhar NS, Md Zin NH, Hamid THTA. | Trop Life Sci Res | 10.21315/tlsr2017.28.2.8 | 2017 | | |
| Pathogenicity | Anandamide alters the membrane properties, halts the cell division and prevents drug efflux in multidrug resistant Staphylococcus aureus. | Banerjee S, Sionov RV, Feldman M, Smoum R, Mechoulam R, Steinberg D. | Sci Rep | 10.1038/s41598-021-88099-6 | 2021 | |
| Plasma-induced nanostructured metallic silver surfaces: study of bacteriophobic effect to avoid bacterial adhesion on medical devices. | Garcia-Bonillo C, Texido R, Gilabert-Porres J, Borros S. | Heliyon | 10.1016/j.heliyon.2022.e10842 | 2022 | | |
| Pathogenicity | Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus. | Feldman M, Smoum R, Mechoulam R, Steinberg D. | Sci Rep | 10.1038/s41598-018-35793-7 | 2018 | |
| Zur antimikrobiellen und viruziden Wirkung eines Hals- und Rachensprays auf der Basis von Hexamidin. | Rheinbaben FV, Kohnlein J, Naujox K, Werner S. | Krankenhaushyg Infektionsverhut | 10.1016/j.khinf.2016.12.001 | 2016 | | |
| Pathogenicity | Designed Antimicrobial Peptides Against Trauma-Related Cutaneous Invasive Fungal Wound Infections. | Woodburn KW, Jaynes JM, Clemens LE. | J Fungi (Basel) | 10.3390/jof6030184 | 2020 | |
| Molecular characterization of antibiotic-resistant Staphylococcus aureus from livestock (bovine and swine). | Zehra A, Singh R, Kaur S, Gill JPS. | Vet World | 10.14202/vetworld.2017.598-604 | 2017 | | |
| Developing Novel Antimicrobial and Antiviral Textile Products. | Iyigundogdu ZU, Demir O, Asutay AB, Sahin F. | Appl Biochem Biotechnol | 10.1007/s12010-016-2275-5 | 2017 | | |
| Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms. | Pinto RM, Soares FA, Reis S, Nunes C, Van Dijck P. | Front Microbiol | 10.3389/fmicb.2020.00952 | 2020 | | |
| Discovery and initial structure-activity relationships of N-benzyl tricyclic indolines as antibacterials for methicillin-resistant Staphylococcus aureus. | Michael Barbour P, Podoll JD, Marholz LJ, Wang X. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2014.10.094 | 2014 | | |
| Chitosan-Coated Polymeric Silver and Gold Nanoparticles: Biosynthesis, Characterization and Potential Antibacterial Applications: A Review. | Huq MA, Ashrafudoulla M, Parvez MAK, Balusamy SR, Rahman MM, Kim JH, Akter S. | Polymers (Basel) | 10.3390/polym14235302 | 2022 | | |
| Enzymology | Nasal Carriage of Staphylococcus aureus among Children in the Ashanti Region of Ghana. | Eibach D, Nagel M, Hogan B, Azuure C, Krumkamp R, Dekker D, Gajdiss M, Brunke M, Sarpong N, Owusu-Dabo E, May J. | PLoS One | 10.1371/journal.pone.0170320 | 2017 | |
| Expression of enterotoxin-coding genes in methicillin-resistant Staphylococcus aureus strains isolated from Mexican haemodialysis patients. | Paniagua-Contreras GL, Monroy-Perez E, Vaca-Paniagua F, Rodriguez-Moctezuma JR, Vaca S. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-014-0055-z | 2014 | | |
| Aquatic Peptide: The Potential Anti-Cancer and Anti-Microbial Activity of GE18 Derived from Pathogenic Fungus Aphanomyces invadans. | Velayutham M, Priya PS, Sarkar P, Murugan R, Almutairi BO, Arokiyaraj S, Kari ZA, Tellez-Isaias G, Guru A, Arockiaraj J. | Molecules | 10.3390/molecules28186746 | 2023 | | |
| Pathogenicity | Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus. | Chiu HC, Lee SL, Kapuriya N, Wang D, Chen YR, Yu SL, Kulp SK, Teng LJ, Chen CS. | Bioorg Med Chem | 10.1016/j.bmc.2012.06.018 | 2012 | |
| Implementation of a novel in vitro model of infection of reconstituted human epithelium for expression of virulence genes in methicillin-resistant Staphylococcus aureus strains isolated from catheter-related infections in Mexico. | Paniagua-Contreras GL, Monroy-Perez E, Vaca-Paniagua F, Rodriguez-Moctezuma JR, Negrete-Abascal E, Vaca S. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-13-6 | 2014 | | |
| Effect on Microbial Growth of a New Skin Protectant Formulation. | Stoffel J, Bernatchez SF. | Adv Wound Care (New Rochelle) | 10.1089/wound.2016.0706 | 2017 | | |
| Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampin against Multidrug- and Extensively Drug-Resistant Pseudomonas aeruginosa. | Domalaon R, Sanchak Y, Koskei LC, Lyu Y, Zhanel GG, Arthur G, Schweizer F. | Antimicrob Agents Chemother | 10.1128/aac.02374-17 | 2018 | | |
| Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms. | Huang R, Zhou Z, Lan X, Tang FK, Cheng T, Sun H, Cham-Fai Leung K, Li X, Jin L. | Mater Today Bio | 10.1016/j.mtbio.2022.100507 | 2023 | | |
| Pathogenicity | Antimicrobial Studies Using the Therapeutic Tissue Cross-Linking Agent, Sodium Hydroxymethylglycinate: Implication for Treating Infectious Keratitis. | Rapuano PB, Scanameo AH, Amponin DE, Paulose SA, Zyablitskaya M, Takaoka A, Suh LH, Nagasaki T, Trokel SL, Paik DC. | Invest Ophthalmol Vis Sci | 10.1167/iovs.17-23111 | 2018 | |
| Pathogenicity | The development of antimicrobial gamma-AApeptides. | She F, Oyesiku O, Zhou P, Zhuang S, Koenig DW, Cai J. | Future Med Chem | 10.4155/fmc-2016-0034 | 2016 | |
| Trichoderma-Derived Pentapeptides from the Infected Nest Mycobiome of the Subterranean Termite Coptotermes testaceus. | Oberpaul M, Brinkmann S, Spohn MS, Mihajlovic S, Marner M, Patras MA, Toti L, Kurz M, Hammann PE, Vilcinskas A, Glaeser J, Schaberle TF. | Chembiochem | 10.1002/cbic.202100698 | 2022 | | |
| Antimicrobial Peptides from Rat-Tailed Maggots of the Drone Fly Eristalis tenax Show Potent Activity against Multidrug-Resistant Gram-Negative Bacteria. | Hirsch R, Wiesner J, Bauer A, Marker A, Vogel H, Hammann PE, Vilcinskas A. | Microorganisms | 10.3390/microorganisms8050626 | 2020 | | |
| "One-stop" synergistic strategy for hepatocellular carcinoma postoperative recurrence. | Liu Y, Tian C, Zhang C, Liu Z, Li J, Li Y, Zhang Q, Ma S, Jiao D, Han X, Zhao Y. | Mater Today Bio | 10.1016/j.mtbio.2023.100746 | 2023 | | |
| Pathogenicity | A model for evaluating topical antimicrobial efficacy against methicillin-resistant Staphylococcus aureus biofilms in superficial murine wounds. | Roche ED, Renick PJ, Tetens SP, Carson DL. | Antimicrob Agents Chemother | 10.1128/aac.00467-12 | 2012 | |
| Pathogenicity | Effect of United States buckwheat honey on antibiotic-resistant hospital acquired pathogens. | Hammond EN, Duster M, Musuuza JS, Safdar N. | Pan Afr Med J | 10.11604/pamj.2016.25.212.10414 | 2016 | |
| Unravelling the synthetic and therapeutic aspects of five, six and fused heterocycles using Vilsmeier-Haack reagent. | Chahal M, Dhillon S, Rani P, Kumari G, Aneja DK, Kinger M. | RSC Adv | 10.1039/d3ra04309f | 2023 | | |
| Genetics | Genome Shuffling of Mangrove Endophytic Aspergillus luchuensis MERV10 for Improving the Cholesterol-Lowering Agent Lovastatin under Solid State Fermentation. | El-Gendy MM, Al-Zahrani HA, El-Bondkly AM. | Mycobiology | 10.5941/myco.2016.44.3.171 | 2016 | |
| Multicenter Evaluation of the Acuitas AMR Gene Panel for Detection of an Extended Panel of Antimicrobial Resistance Genes among Bacterial Isolates. | Simner PJ, Musser KA, Mitchell K, Wise MG, Lewis S, Yee R, Bergman Y, Good CE, Abdelhamed AM, Li H, Laseman EM, Sahm D, Pitzer K, Quan J, Walker GT, Jacobs MR, Rhoads DD. | J Clin Microbiol | 10.1128/jcm.02098-21 | 2022 | | |
| The Influence of Carrier Oils on the Antimicrobial Activity and Cytotoxicity of Essential Oils. | Orchard A, Kamatou G, Viljoen AM, Patel N, Mawela P, van Vuuren SF. | Evid Based Complement Alternat Med | 10.1155/2019/6981305 | 2019 | | |
| Pathogenicity | NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus. | Mercer DK, Katvars LK, Hewitt F, Smith DW, Robertson J, O'Neil DA. | Antimicrob Agents Chemother | 10.1128/aac.00502-17 | 2017 | |
| Pathogenicity | Chitosan augments photodynamic inactivation of gram-positive and gram-negative bacteria. | Tsai T, Chien HF, Wang TH, Huang CT, Ker YB, Chen CT. | Antimicrob Agents Chemother | 10.1128/aac.00550-10 | 2011 | |
| Pathogenicity | Derivatives of Ribosome-Inhibiting Antibiotic Chloramphenicol Inhibit the Biosynthesis of Bacterial Cell Wall. | Louzoun Zada S, Green KD, Shrestha SK, Herzog IM, Garneau-Tsodikova S, Fridman M. | ACS Infect Dis | 10.1021/acsinfecdis.8b00078 | 2018 | |
| Recent Progress in the Development of Small-Molecule FtsZ Inhibitors as Chemical Tools for the Development of Novel Antibiotics. | Carro L. | Antibiotics (Basel) | 10.3390/antibiotics8040217 | 2019 | | |
| Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus. | Sashidhara KV, Rao KB, Kushwaha P, Modukuri RK, Singh P, Soni I, Shukla PK, Chopra S, Pasupuleti M. | ACS Med Chem Lett | 10.1021/acsmedchemlett.5b00169 | 2015 | | |
| Evaluation of the Antimicrobial Peptide, RP557, for the Broad-Spectrum Treatment of Wound Pathogens and Biofilm. | Woodburn KW, Jaynes JM, Clemens LE. | Front Microbiol | 10.3389/fmicb.2019.01688 | 2019 | | |
| Metabolism | Highly potent antimicrobial peptides from N-terminal membrane-binding region of E. coli MreB. | Saikia K, Sravani YD, Ramakrishnan V, Chaudhary N. | Sci Rep | 10.1038/srep42994 | 2017 | |
| Phylogeny | Acceleration of the direct identification of Staphylococcus aureus versus coagulase-negative staphylococci from blood culture material: a comparison of six bacterial DNA extraction methods. | Loonen AJ, Jansz AR, Kreeftenberg H, Bruggeman CA, Wolffs PF, van den Brule AJ. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-010-1090-0 | 2011 | |
| Guanidylation and tail effects in cationic antimicrobial lipopeptoids. | Findlay B, Szelemej P, Zhanel GG, Schweizer F. | PLoS One | 10.1371/journal.pone.0041141 | 2012 | | |
| Pathogenicity | Antimicrobial and antiproliferative activities of stingless bee Melipona scutellaris geopropolis. | da Cunha MG, Franchin M, de Carvalho Galvao LC, de Ruiz AL, de Carvalho JE, Ikegaki M, de Alencar SM, Koo H, Rosalen PL. | BMC Complement Altern Med | 10.1186/1472-6882-13-23 | 2013 | |
| Application of tetracycline hydrochloride loaded-fungal chitosan and Aloe vera extract based composite sponges for wound dressing. | Anbazhagan S, Thangavelu KP. | J Adv Res | 10.1016/j.jare.2018.05.005 | 2018 | | |
| Untersuchungen zur mikrobistatischen, viruziden und antiviralen Wirksamkeit eines antiseptischen Präparates basierend auf Amylmetacresol, 2,4-Dichlorbenzylalkohol und Levomenthol. | Kohnlein J, Rheinbaben FV, Werner S. | Krankenhaushyg Infektionsverhut | 10.1016/j.khinf.2016.09.004 | 2016 | | |
| Pathogenicity | 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents. | Hansa RK, Khan MMK, Frangie MM, Gilmore DF, Shelton RS, Savenka AV, Basnakian AG, Shuttleworth SL, Smeltzer MS, Alam MA. | Eur J Med Chem | 10.1016/j.ejmech.2021.113402 | 2021 | |
| Targeting Bacterial Cell Division: A Binding Site-Centered Approach to the Most Promising Inhibitors of the Essential Protein FtsZ. | Casiraghi A, Suigo L, Valoti E, Straniero V. | Antibiotics (Basel) | 10.3390/antibiotics9020069 | 2020 | | |
| Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities. | Tripathi AK, Kumari T, Harioudh MK, Yadav PK, Kathuria M, Shukla PK, Mitra K, Ghosh JK. | Sci Rep | 10.1038/s41598-017-03576-1 | 2017 | | |
| Metabolism | Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. | Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G. | PLoS One | 10.1371/journal.pone.0006788 | 2009 | |
| Enzymology | A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin. | Al-Talib H, Yean CY, Al-Khateeb A, Hassan H, Singh KK, Al-Jashamy K, Ravichandran M. | BMC Microbiol | 10.1186/1471-2180-9-113 | 2009 | |
| Molecular Typing of ST239-MRSA-III From Diverse Geographic Locations and the Evolution of the SCCmec III Element During Its Intercontinental Spread. | Monecke S, Slickers P, Gawlik D, Muller E, Reissig A, Ruppelt-Lorz A, Akpaka PE, Bandt D, Bes M, Boswihi SS, Coleman DC, Coombs GW, Dorneanu OS, Gostev VV, Ip M, Jamil B, Jatzwauk L, Narvaez M, Roberts R, Senok A, Shore AC, Sidorenko SV, Skakni L, Somily AM, Syed MA, Thurmer A, Udo EE, Vremera T, Zurita J, Ehricht R. | Front Microbiol | 10.3389/fmicb.2018.01436 | 2018 | | |
| Pathogenicity | Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model. | Biel MA, Pedigo L, Gibbs A, Loebel N. | Int Forum Allergy Rhinol | 10.1002/alr.21134 | 2013 | |
| Pathogenicity | Antibacterial activity of ultrashort cationic lipo-beta-peptides. | Serrano GN, Zhanel GG, Schweizer F. | Antimicrob Agents Chemother | 10.1128/aac.01100-08 | 2009 | |
| Guanidine-Containing Polyhydroxyl Macrolides: Chemistry, Biology, and Structure-Activity Relationship. | Song X, Yuan G, Li P, Cao S. | Molecules | 10.3390/molecules24213913 | 2019 | | |
| Pathogenicity | Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria. | Alkhaibari IS, Kc HR, Roy S, Abu-Gazleh MK, Gilmore DF, Alam MA. | Molecules | 10.3390/molecules26165083 | 2021 | |
| Bioactivity of the Genus Turnera: A Review of the Last 10 Years. | Parra-Naranjo A, Delgado-Montemayor C, Salazar-Aranda R, Waksman-Minsky N. | Pharmaceuticals (Basel) | 10.3390/ph16111573 | 2023 | | |
| Antimicrobial Activity of Calixarenes and Related Macrocycles. | Shurpik DN, Padnya PL, Stoikov II, Cragg PJ. | Molecules | 10.3390/molecules25215145 | 2020 | | |
| Pathogenicity | In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate. | Clouse FL, Hovde LB, Rotschafer JC. | Antimicrob Agents Chemother | 10.1128/aac.00435-07 | 2007 | |
| Pathogenicity | In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. | Idelevich EA, von Eiff C, Friedrich AW, Iannelli D, Xia G, Peters G, Peschel A, Wanninger I, Becker K. | Antimicrob Agents Chemother | 10.1128/aac.00217-11 | 2011 | |
| Pathogenicity | Potent bactericidal efficacy of copper oxide impregnated non-porous solid surfaces. | Monk AB, Kanmukhla V, Trinder K, Borkow G. | BMC Microbiol | 10.1186/1471-2180-14-57 | 2014 | |
| Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases. | Orchard A, van Vuuren S. | Evid Based Complement Alternat Med | 10.1155/2017/4517971 | 2017 | | |
| Piscidin-1-analogs with double L- and D-lysine residues exhibited different conformations in lipopolysaccharide but comparable anti-endotoxin activities. | Kumar A, Kumar A, Mahajan M, Awasthi B, Tandon A, Harioudh MK, Shree S, Singh P, Shukla PK, Ramachandran R, Mitra K, Bhattacharjya S, Ghosh JK. | Sci Rep | 10.1038/srep39925 | 2017 | | |
| Pathogenicity | Prevalence of antibiotic resistance in multi-drug resistant coagulase-negative staphylococci isolated from invasive infection in very low birth weight neonates in two Polish NICUs. | Brzychczy-Wloch M, Borszewska-Kornacka M, Gulczynska E, Wojkowska-Mach J, Sulik M, Grzebyk M, Luchter M, Heczko PB, Bulanda M. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-12-41 | 2013 | |
| The In Vitro Antimicrobial Activity of Lavandula angustifolia Essential Oil in Combination with Other Aroma-Therapeutic Oils. | de Rapper S, Kamatou G, Viljoen A, van Vuuren S. | Evid Based Complement Alternat Med | 10.1155/2013/852049 | 2013 | | |
| Pathogenicity | Evaluation of new Vitek 2 card and disk diffusion method for determining susceptibility of Staphylococcus aureus to oxacillin. | Roisin S, Nonhoff C, Denis O, Struelens MJ. | J Clin Microbiol | 10.1128/jcm.00291-08 | 2008 | |
| Pathogenicity | Bio-inspired synthesis yields a tricyclic indoline that selectively resensitizes methicillin-resistant Staphylococcus aureus (MRSA) to beta-lactam antibiotics. | Podoll JD, Liu Y, Chang L, Walls S, Wang W, Wang X. | Proc Natl Acad Sci U S A | 10.1073/pnas.1310459110 | 2013 | |
| Synthesis of several cleistrioside and cleistetroside natural products via a divergent de novo asymmetric approach. | Wu B, Li M, O'Doherty GA. | Org Lett | 10.1021/ol1023344 | 2010 | | |
| Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens. | Das B, Sarkar C, Das D, Gupta A, Kalra A, Sahni S. | Ther Adv Infect Dis | 10.1177/2049936117690501 | 2017 | | |
| Synthesis and preliminary anti-inflammatory and anti-bacterial evaluation of some diflunisal aza-analogs. | Carta D, Brun P, Dal Pra M, Bernabe G, Castagliuolo I, Ferlin MG. | Medchemcomm | 10.1039/c8md00139a | 2018 | | |
| Phylogeny | Comparison of fingerprinting methods for typing methicillin-resistant Staphylococcus aureus sequence type 398. | Rasschaert G, Vanderhaeghen W, Dewaele I, Janez N, Huijsdens X, Butaye P, Heyndrickx M. | J Clin Microbiol | 10.1128/jcm.00910-09 | 2009 | |
| Wound dressings from a hygienic point of view using the example of sorbion sachet S. | Kramer A, Maassen A. | GMS Krankenhhyg Interdiszip | 10.3205/dgkh000136 | 2009 | | |
| Effects of temperature and humidity on the efficacy of methicillin-resistant Staphylococcus aureus challenged antimicrobial materials containing silver and copper. | Michels HT, Noyce JO, Keevil CW. | Lett Appl Microbiol | 10.1111/j.1472-765x.2009.02637.x | 2009 | | |
| Pathogenicity | Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. | Lemaire S, Glupczynski Y, Duval V, Joris B, Tulkens PM, Van Bambeke F. | Antimicrob Agents Chemother | 10.1128/aac.01135-08 | 2009 | |
| Pathogenicity | Antimicrobial AApeptides. | Sang P, Shi Y, Teng P, Cao A, Xu H, Li Q, Cai J. | Curr Top Med Chem | 10.2174/1568026616666161018145945 | 2017 | |
| Pathogenicity | Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection. | Ghosh C, Manjunath GB, Konai MM, Uppu DS, Hoque J, Paramanandham K, Shome BR, Haldar J. | PLoS One | 10.1371/journal.pone.0144094 | 2015 | |
| Metabolism | Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. | Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, Bernhardt W, von Eiff C, Becker K, Schafer A, Peschel A, Kempf VA. | PLoS One | 10.1371/journal.pone.0011576 | 2010 | |
| Development of Antimicrobial Phototreatment Tolerance: Why the Methodology Matters. | Rapacka-Zdonczyk A, Wozniak A, Nakonieczna J, Grinholc M. | Int J Mol Sci | 10.3390/ijms22042224 | 2021 | | |
| Pathogenicity | Liposomes-in-hydrogel delivery system with mupirocin: in vitro antibiofilm studies and in vivo evaluation in mice burn model. | Hurler J, Sorensen KK, Fallarero A, Vuorela P, Skalko-Basnet N. | Biomed Res Int | 10.1155/2013/498485 | 2013 | |
| Metabolism | Syk/Src pathway-targeted inhibition of skin inflammatory responses by carnosic acid. | Oh J, Yu T, Choi SJ, Yang Y, Baek HS, An SA, Kwon LK, Kim J, Rho HS, Shin SS, Choi WS, Hong S, Cho JY. | Mediators Inflamm | 10.1155/2012/781375 | 2012 | |
| Pathogenicity | Rapid identification of methicillin-resistant Staphylococcus aureus and simultaneous species confirmation using real-time fluorescence PCR. | Reischl U, Linde HJ, Metz M, Leppmeier B, Lehn N. | J Clin Microbiol | 10.1128/jcm.38.6.2429-2433.2000 | 2000 | |
| Pathogenicity | In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood. | von Eiff C, Kokai-Kun JF, Becker K, Peters G. | Antimicrob Agents Chemother | 10.1128/aac.47.11.3613-3615.2003 | 2003 | |
| Pathogenicity | 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii. | Tseng SP, Hung WC, Huang CY, Lin YS, Chan MY, Lu PL, Lin L, Sheu JH. | Mar Drugs | 10.3390/md14080143 | 2016 | |
| Pathogenicity | Rapid detection of oxacillin-resistant Staphylococcus aureus in blood cultures by an impedance method. | Wu JJ, Huang AH, Dai JH, Chang TC. | J Clin Microbiol | 10.1128/jcm.35.6.1460-1464.1997 | 1997 | |
| Pathogenicity | Structure-activity relationship studies of the tricyclic indoline resistance-modifying agent. | Chang L, Podoll JD, Wang W, Walls S, O'Rourke CP, Wang X. | J Med Chem | 10.1021/jm500146g | 2014 | |
| Pathogenicity | Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions. | Wright DH, Gunderson BW, Hovde LB, Ross GH, Ibrahim KH, Rotschafer JC. | Antimicrob Agents Chemother | 10.1128/aac.46.5.1561-1563.2002 | 2002 | |
| Pathogenicity | New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. | Huletsky A, Giroux R, Rossbach V, Gagnon M, Vaillancourt M, Bernier M, Gagnon F, Truchon K, Bastien M, Picard FJ, van Belkum A, Ouellette M, Roy PH, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.42.5.1875-1884.2004 | 2004 | |
| Pathogenicity | Development of Tyrocidine A analogues with improved antibacterial activity. | Marques MA, Citron DM, Wang CC. | Bioorg Med Chem | 10.1016/j.bmc.2007.08.007 | 2007 | |
| Metabolism | Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus. | Lemaire S, Tulkens PM, Van Bambeke F. | Antimicrob Agents Chemother | 10.1128/aac.01201-10 | 2011 | |
| Metabolism | Dying blood mononuclear cell secretome exerts antimicrobial activity. | Kasiri MM, Beer L, Nemec L, Gruber F, Pietkiewicz S, Haider T, Simader EM, Traxler D, Schweiger T, Janik S, Taghavi S, Gabriel C, Mildner M, Ankersmit HJ. | Eur J Clin Invest | 10.1111/eci.12667 | 2016 | |
| Porcine Models of Biofilm Infections with Focus on Pathomorphology. | Jensen LK, Johansen ASB, Jensen HE. | Front Microbiol | 10.3389/fmicb.2017.01961 | 2017 | | |
| Phylogeny | Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures. | Maes N, Magdalena J, Rottiers S, De Gheldre Y, Struelens MJ. | J Clin Microbiol | 10.1128/jcm.40.4.1514-1517.2002 | 2002 | |
| Pathogenicity | Oxacillin susceptibility testing of staphylococci directly from Bactec Plus blood cultures by the BBL Crystal MRSA ID system. | Kubina M, Jaulhac B, Delabranche X, Lindenmann C, Piemont Y, Monteil H. | J Clin Microbiol | 10.1128/jcm.37.6.2034-2036.1999 | 1999 | |
| Pathogenicity | Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model. | Hermsen ED, Hovde LB, Hotchkiss JR, Rotschafer JC. | Antimicrob Agents Chemother | 10.1128/aac.47.12.3764-3767.2003 | 2003 | |
| Pathogenicity | Photodynamic disinfection and its role in controlling infectious diseases. | Aroso RT, Schaberle FA, Arnaut LG, Pereira MM. | Photochem Photobiol Sci | 10.1007/s43630-021-00102-1 | 2021 | |
| Enzymology | Species-specific and ubiquitous-DNA-based assays for rapid identification of Staphylococcus aureus. | Martineau F, Picard FJ, Roy PH, Ouellette M, Bergeron MG. | J Clin Microbiol | 10.1128/jcm.36.3.618-623.1998 | 1998 | |
| Stilbenoids: A Natural Arsenal against Bacterial Pathogens. | Mattio LM, Catinella G, Dallavalle S, Pinto A. | Antibiotics (Basel) | 10.3390/antibiotics9060336 | 2020 | | |
| Phylogeny | Staph ID/R: a rapid method for determining staphylococcus species identity and detecting the mecA gene directly from positive blood culture. | Pasko C, Hicke B, Dunn J, Jaeckel H, Nieuwlandt D, Weed D, Woodruff E, Zheng X, Jenison R. | J Clin Microbiol | 10.1128/jcm.05534-11 | 2012 | |
| Pathogenicity | Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. | Louie L, Matsumura SO, Choi E, Louie M, Simor AE. | J Clin Microbiol | 10.1128/jcm.38.6.2170-2173.2000 | 2000 | |
| Enzymology | Rapid detection of methicillin-resistant Staphylococcus aureus by Crystal MRSA ID System. | Qadri SM, Ueno Y, Imambaccus H, Almodovar E. | J Clin Microbiol | 10.1128/jcm.32.7.1830-1832.1994 | 1994 | |
| Pathogenicity | Rapid solid-phase immunoassay for detection of methicillin-resistant Staphylococcus aureus using cycling probe technology. | Fong WK, Modrusan Z, McNevin JP, Marostenmaki J, Zin B, Bekkaoui F. | J Clin Microbiol | 10.1128/jcm.38.7.2525-2529.2000 | 2000 | |
| Potential of Flow Cytometric Approaches for Rapid Microbial Detection and Characterization in the Food Industry-A Review. | Zand E, Froehling A, Schoenher C, Zunabovic-Pichler M, Schlueter O, Jaeger H. | Foods | 10.3390/foods10123112 | 2021 | | |
| Design and Application of Antimicrobial Peptide Conjugates. | Reinhardt A, Neundorf I. | Int J Mol Sci | 10.3390/ijms17050701 | 2016 | | |
| Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? | Domalaon R, Idowu T, Zhanel GG, Schweizer F. | Clin Microbiol Rev | 10.1128/cmr.00077-17 | 2018 | | |
| Dual functional polyelectrolyte multilayer coatings for implants: permanent microbicidal base with controlled release of therapeutic agents. | Wong SY, Moskowitz JS, Veselinovic J, Rosario RA, Timachova K, Blaisse MR, Fuller RC, Klibanov AM, Hammond PT. | J Am Chem Soc | 10.1021/ja106288c | 2010 | | |
| Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections. | Hu X, Huang YY, Wang Y, Wang X, Hamblin MR. | Front Microbiol | 10.3389/fmicb.2018.01299 | 2018 | | |
| Plate-associated localized osteitis in mini-pig by biofilm-forming Methicillin-resistant Staphylococcus aureus (MRSA): establishment of a novel experimental model. | Jaekel C, Windolf CD, Sager M, Wollschlager LM, Hoffmanns M, Grassmann JP | Eur J Trauma Emerg Surg | 10.1007/s00068-022-01894-2 | 2022 | | |
| Pathogenicity | Sustainable Low-Volume Analysis of Environmental Samples by Semi-Automated Prioritization of Extracts for Natural Product Research (SeaPEPR). | Riyanti, Marner M, Hartwig C, Patras MA, Wodi SIM, Rieuwpassa FJ, Ijong FG, Balansa W, Schaberle TF | Mar Drugs | 10.3390/md18120649 | 2020 | |
| Antibacterial Activity of Silver Nanoparticles (AgNP) Confined to Mesostructured, Silica-Based Calcium Phosphate Against Methicillin-Resistant Staphylococcus Aureus (MRSA). | Kung JC, Wang WH, Lee CL, Hsieh HC, Shih CJ | Nanomaterials (Basel) | 10.3390/nano10071264 | 2020 | | |
| Pathogenicity | Defense involvement of piscidin from striped murrel Channa striatus and its peptides CsRG12 and CsLC11 involvement in an antimicrobial and antibiofilm activity. | Stefi Raju V, Sarkar P, Pachaiappan R, Paray BA, Al-Sadoon MK, Arockiaraj J | Fish Shellfish Immunol | 10.1016/j.fsi.2020.02.027 | 2020 | |
| Pathogenicity | Silver Nanoparticles Synthesized by Using the Endophytic Bacterium Pantoea ananatis are Promising Antimicrobial Agents against Multidrug Resistant Bacteria. | Monowar T, Rahman MS, Bhore SJ, Raju G, Sathasivam KV | Molecules | 10.3390/molecules23123220 | 2018 | |
| Pathogenicity | In vitro antimicrobial activity of plants used in traditional medicine in Gurage and Silti Zones, south central Ethiopia. | Teka A, Rondevaldova J, Asfaw Z, Demissew S, Van Damme P, Kokoska L, Vanhove W | BMC Complement Altern Med | 10.1186/s12906-015-0822-1 | 2015 | |
| Pathogenicity | Anti-methicillin-resistant Staphylococcus aureus assay of azalomycin F5a and its derivatives. | Yuan GJ, Li PB, Yang J, Pang HZ, Pei Y | Chin J Nat Med | 10.1016/S1875-5364(14)60061-3 | 2014 | |
| Pathogenicity | Inspiration from old dyes: tris(stilbene) compounds as potent gram-positive antibacterial agents. | Boulos RA, Man NY, Lengkeek NA, Hammer KA, Foster NF, Stemberger NA, Skelton BW, Wong PY, Martinac B, Riley TV, McKinley AJ, Stewart SG | Chemistry | 10.1002/chem.201303119 | 2013 | |
| Pathogenicity | Reducing the risk of infection in vascular access patients: an in vitro evaluation of an antimicrobial silver nanotechnology luer activated device. | Edmiston CE Jr, Markina V | Am J Infect Control | 10.1016/j.ajic.2009.09.010 | 2010 | |
| Pathogenicity | Syntheses of carnosic acid and carnosol, anti-oxidants in Rosemary, from pisiferic acid, the major constituent of Sawara. | Tada M, Ohkanda T, Kurabe J | Chem Pharm Bull (Tokyo) | 10.1248/cpb.58.27 | 2010 | |
| Pathogenicity | Antibacterial activity of anacardic acid and totarol, alone and in combination with methicillin, against methicillin-resistant Staphylococcus aureus. | Muroi H, Kubo I | J Appl Bacteriol | 10.1111/j.1365-2672.1996.tb03233.x | 1996 | |
| Phylogeny | Isolation, Molecular Identification and Antibacterial Potential of Marine Bacteria from Deep Atlantic Ocean of Morocco. | Chbel A, Rodriguez-Castro J, Quinteiro J, Rey-Mendez M, Delgado AS, Soukri A, Khalfi BE | Avicenna J Med Biotechnol | 10.18502/ajmb.v14i3.9827 | 2022 | |
| Metabolism | Production of the antimicrobial compound tetrabromopyrrole and the Pseudomonas quinolone system precursor, 2-heptyl-4-quinolone, by a novel marine species Pseudoalteromonas galatheae sp. nov. | Paulsen SS, Isbrandt T, Kirkegaard M, Buijs Y, Strube ML, Sonnenschein EC, Larsen TO, Gram L. | Sci Rep | 10.1038/s41598-020-78439-3 | 2020 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14460.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License